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Abstract

Previous research has shown that recurrent miscarriage is associated with unsuccessful
outcomes in future pregnancies. There is limited research on its impact on obstetric
outcomes and behaviors during subsequent pregnancies, especially in the region. This
dissertation aims to identify the behaviors of women during their index pregnancies
and outcomes during delivery with regards to a history of recurrent miscarriage as well
as the chronology of the recurrent miscarriage. This dissertation is an interim analysis
of a prospective cohort study on 10,000 pregnant women who joined the Mutaba ah
Study cohort between May 2017 and April 2019. Participants were recruited during
antenatal care visits and completed a self-administered questionnaire that collected
socio-demographic and pregnancy-related information. Data on past pregnancy
history, progress of the current pregnancy, and outcomes of the mother and child in
the index pregnancy were extracted from hospital medical records. Regression models
assessed the relationship between a history of recurrent miscarriage and maternal
outcomes and behaviors during their index pregnancy. Overall, 234 (13.5%) women
had a history of two or more consecutive miscarriages out of 1,737 women who had a
previous gravidity of two or more. Recurrent miscarriage was independently
associated with an increased likelihood of cesarean section, preterm, and very preterm
births in future pregnancies. Women with history of recurrent miscarriage were more
likely to be on time for their antenatal care initiation and consume folate daily prior to
their future pregnancy. Recurrent loss occurring immediately before the index
pregnancy was more associated with participants having planned pregnancies and
consuming folate daily before pregnancy. This is the first work in the United Arab
Emirates to investigate recurrent miscarriage and its impact. It will pave the way for
focused management of future pregnancies to reduce the impact of adverse outcomes
such as cesarean section and preterm deliveries as well as improve behaviors of women
with a history of loss. Recurrent loss in the population is relatively high in this
population of pregnant women in the Emirati population and requires public health
attention.
Keywords: Cohort studies, recurrent miscarriage, miscarriage, cesarean section,
preterm birth, pregnancy.
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Chapter 1: Introduction

1.1 Overview
Maternal and child health around the world has improved tremendously in the last few
decades [1]. The improvement of health in mothers and children rely dominantly in
the continuum of care from human conception, pregnancy, delivery, post-pregnancy,
newborns to childhood. The continuum of care is reliant on care at all stages from
conception to birth. At times however, the first step of human conception is flawed
and ends in miscarriages [2]. Women who go through miscarriages often go through
many poor outcomes both during the miscarriage and after it during their reproductive
career. Furthermore, miscarriages can manifest in multiple numbers in a woman s
reproductive career in the form of recurrent miscarriages (RM). While some women
who have a history of RM go on to have healthy live births in the future, some do not.
From the Mutaba ah study, a prospective cohort on maternal and child health, a cohort
of pregnant women with a history of RM was investigated thoroughly to understand
their futures after loss.
1.2 Statement of the Problem
The RM literature in the United Arab Emirates (UAE) is scarce. Continuum of care in
pregnancy and beyond is not possible without understanding the extent of prevalence
of RM and its effects on women who go on to have viable pregnancies. Reproductive
history is a vital factor in improving future pregnancy outcomes. Thus, it is necessary
to map the impact of RM in the characteristics of the women who experience it as well
as describe the pregnancy-related lifestyles and outcomes in future pregnancies of the
Emirati pregnant population with a history of RM. To understand these developments,
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there is a pertinent need to follow women with a history of RM to outline the issues
they face in their future pregnancies.
1.3 Relevant Literature
1.3.1 Reproductive Health
A pregnancy is on average a 37 to 40 week process from conception to birth in which
one or more offspring develop inside the woman [3]. Most pregnancies are dated from
the last da of the woman s last menstrual period (LMP) to the day she delivers.
Pregnancy is looked at in three sections or trimesters: between weeks 1 to 12, weeks
13 to 28 and finally, weeks 29 to 40 [4].
Basic fetal cell differentiations occur during weeks one to twelve. Any issues with this
cell differentiation often result in a miscarriage or disability upon delivery. In the early
embryo, cells are pluripotent which indicates that they can turn into any cell of the
human body. If embryonic cells cannot enter the state of pluri-potency for
differentiation due to issues such as transcription errors or implantation failure, they
fail to differentiate into various cell types and the embryo is not viable and is
incompatible with life [5]. Furthermore, during the time of implantation, the
endometrium of the woman prepares for pregnancy. Stromal cells will differentiate
into decidual cells [6]. The lack of decidualization during this process of differentiation
will break down the feto-maternal interface causing miscarriages [7]. First trimester
fetuses do not survive outside the womb even with medical interventions as the organ
systems of the fetus are severely under-developed. Upon reaching the second trimester,
the fetus experiences significant developments. Physical parts such as the heart and
limbs become distinct and operational to a certain level. A baby born during the second
trimester might have chances of survival but even if it does survive, chances are it
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would go on to experience developmental delays and other disabilities, albeit later in
life. In the final trimester, fetuses begin preparation for birth. They move into a position
at the lower abdomen of the mother. A pregnancy usually ends when the birth process
begins [8].
Pregnancy, fetal development, birth and miscarriages all encompass maternal and child
health. Maternal and child health has been a key health issue of many health systems
and a significant focus in international health organizations. The World Health
Organization (WHO) has consistently pushed for better health for this vulnerable
populations. The Sustainable Development Goals (SDG), and previously the
Millennium Development Goals, constantly pushed for reduced maternal mortality,
lower adverse outcomes at birth and healthcare to ensure sustainable life for the
newborns [9]. SDG number 3, which indicates that all countries should ensure healthy
lives and promotion of wellbeing for the entire population at all ages, has multiple subgoals. One of these sub-goals (Goal number 3.2) as per the WHO has indicated that all
preventable deaths of newborns should be ended by 2030 [10]. Mortality manifests
itself in multiple ways during pregnancies and at birth and is not limited to just the
death of a newborn (Figure 1). As pregnancy loss constitutes the death of the fetus, in
this thesis and other literature, it is considered a form of mortality [11]. Despite the
advancement in reproductive health [12], this is a probable unfortunate outcome for
many pregnancies

the possibility of loss at every stage.
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Figure 1: The timeline of a pregnancy showing instances of loss [13]
As Figure 1 depicts, pregnancy loss can occur in the form of miscarriages at different
times of a pregnancy. The following section will describe the nuances of miscarriages
based on its timing, types and frequencies.
1.3.2 Miscarriages
The WHO defines miscarriage as the expulsion of extraction from its mother of an
embryo or fetus weighing <500 grams or before the 22 weeks of gestation [8]. This is
seen as the natural death of an embryo or a fetus before its ability to survive
independently.
A loss during the first 13 weeks of pregnancy or the first trimester is called an early
pregnancy loss, often referred to as early miscarriage, first trimester loss or
spontaneous abortion. A late miscarriage often occurs in the second trimester and
before the 20th week, after which it is considered a stillbirth [14]. According to the
American College of Obstetrics and Gynecology, about 10% of all known pregnancies
(confirmed by blood tests, scans or histology) result in early miscarriages [15].
However, other authors have reported higher incidences as well, at about 12-15% [16].
There are also losses occurring immediately after conception before the next
menstruation cycle. Often confused with actual menstrual bleeding, the incidences of
such miscarriages are much higher with rates ranging from 17 to 22% [17]. As for late
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miscarriages, also sometimes referred to as second- trimester pregnancy loss, the rates
are much lower at about 1% to 4% [18, 19]. Furthermore, miscarriages can be
classified as sporadic or recurrent miscarriages. A sporadic miscarriage is often a onetime event in the life of a woman [20]. Recurrent miscarriages, the focus of this thesis,
are repeated events and would be discussed in detail in the upcoming sections. In
addition, miscarriages can also be classified into missed miscarriages, molar
pregnancies, ectopic pregnancies, and blighted ovums which are described below.
1.3.2.1 Missed miscarriage
A missed miscarriage indicates that the baby has stopped growing or has passed away
but there are no miscarriage symptoms such as bleeding or pain. It is also called a
delayed miscarriage. Due to the lack of miscarriage symptoms, the mother might not
notice the miscarriage till she attends an antenatal appointment. An ultrasound might
reveal that the baby has a lack of heartbeat or is small for gestational age (SGA). To
process the miscarriage, medicine is often given such as misoprostol to process the
abortion of the fetus [21].
1.3.2.2 Molar pregnancy
A molar pregnancy occurs when a non-viable fertilized egg implants on the uterus. It
often develops when a fertilized egg does not contain original maternal nuclei. A molar
pregnancy is often characterized by clusters in the uterus that resemble grapes. Such a
pregnancy can be often seen in early second trimesters with painless vaginal bleeding.
Mothers might experience an increased case of vomiting or hyperemesis, increased
blood pressure along with protein in the urine as well as high levels of human chorionic
gonadotropin (hCG) [22].

6
1.3.2.3 Ectopic pregnancy
An ectopic pregnancy is often due to the fertilized embryo attaching itself outside the
uterus. The classic symptoms of ectopic pregnancies include severe pain in the
abdomen and bleeding which is uncharacteristic for normal pregnancies. Pain also
radiates to the shoulder if bleeding has moved onto the abdomen. Women have been
known to faint, go into shock and experience heart palpitations. The prognosis of an
ectopic pregnancy is often the fetal death except for very rare cases [23].
1.3.2.4 Blighted ovum
A blighted ovum or an-embryonic pregnancy occurs when a fertilized egg attaches
itself to the uterine wall but does not develop into an embryo. Cells start to develop to
produce a gestational sac but never the embryo itself. Occurring within the first
trimester, a blighted ovum often occurs even before the woman is cognizant of her
pregnancy. A blighted ovum has a high level of chromosomal abnormalities which
allows the woman to naturally miscarry. A blighted ovum is one of the leading causes
of very early pregnancy losses at about 50% prevalence [24].

1.3.2.5 Stillbirth
There is some disagreement to whether a stillbirth is a pregnancy loss or the death of
a baby as it occurs towards the end of a pregnancy. Defined as a fetal death that occurs
late in pregnancy, most countries define their own gestational age (between 16 weeks
to 24 weeks) at which a miscarriage is defined as a stillbirth [25]. In the UAE, based
on Islamic laws, a stillbirth occurs at 17 weeks and beyond. This is based on the
interpretations of the Quran and sayings of the Prophet (Hadith) that indicate the
transformation of a fetus into a living person occurs at 120 days from conception [17
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weeks), when an angel breathes the ruh (spirit) into the fetus [26]. The estimated
number of stillbirths worldwide was about 2.64 million in the year 2015 [27]. This
dissertation considers stillbirth to be a fetal outcome at birth rather than a pregnancy
loss which will be solely used for the purposes of discussing miscarriages.
1.3.3 Reasons for Miscarriages
While miscarriages can be defined in many different ways, it is more vital that it is
understood why they happen. The extant scientific literature reports that there are a
multitude of factors and characteristics in a woman that might increase the risk of a
miscarriage. Some of the leading factors and characteristics associated with
miscarriages are explained here, focusing especially on causes and characteristics with
a stronger evidence base in recurrent miscarriage.
1.3.3.1 Maternal age
Maternal age seems to be associated with many adverse outcomes during pregnancy
and delivery. It is specifically a well-known indicator for sporadic miscarriage [28].
Women above the age of 35 years are known to have issues in oocyte development
which in turn leads to embryonic aneuploidy [29, 30]. While women under the age of
35 years have a 14% miscarriage rate per pregnancy, it almost triples for women above
40 years [31].
1.3.3.2 Previous pregnancy losses
There is an increased risk for women who have suffered a previous miscarriage to
suffer a future one. Initial studies investigating the risk of previous miscarriages on
future miscarriages have indicated that the incidence of having a miscarriage after
having one is 12% while the incidence is greater after having two miscarriages at 29%
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[32]. These numbers have been reconsidered in other studies, with the risk rates of
future loss after one previous one being between 2-3% and 0.34% after having suffered
from two miscarriages [33]. This decrease in rates could be due to different population
characteristics and the applied definitions of loss. The denominator used to calculate
the risk of future loss also varies in many studies and includes either women at risk of
loss who have had two or more pregnancies or all women in their reproductive years
or women intending to conceive [34]. The improvement in healthcare facilities as well
as access to care could have also played a part in drastic differences in the risk rates in
different populations.
1.3.3.3 Chromosomal abnormalities
Almost 40% of all miscarriages have some level of chromosomal aberration. It is noted
that this is that these aberrations are incompatible with extra-uterine life [35].
Chromosomal abnormalities may manifest in many ways. Some of the common
abnormalities include autosomal trisom

(e.g. Down s S ndrome) [36]. The

prevalence of translocation in either parent is about 3 to 5% with the mother often
twice as affected by translocation as compared to the father. The advent of pregnancy
loss and fetal abnormalities are often dependent on size, location, and the type of
structural rearrangement of chromosomes [37]. For example, an inversion of the
chromosome, which is caused by a piece of chromosome breaking at two points and
reinserting within the same chromosome, can increase risks of miscarriages as well as
birth defects [38]. If the region of inversion is more than 50% of the length of the
chromosome, risks of miscarrying are significant [39].

9
1.3.3.4 Uterine defects
Uterine defects may refer to uterine congenital malformations, a uni-cornuate, bicornuate or septate uterus, uterus didelphys, cervical incompetence or others. The
incapacity of the cervix in maintaining the pregnancy is defined as cervical
incompetence [35]. While it can be treated by cervical cerclage, cervical incompetence
has been shown to be a cause of miscarriage. The anatomical defects of uni-cornuate,
bi-cornuate and septate uterus all have different values of fetal survival rate. While a
woman who has a septate uterus has a fetal survival rate of 15-28%, another with a
uni-cornuate uterus has a rate of about 40%. Women with bi-cornuate uteruses have
the highest fetal survival rates of about 57% [35]. However, it has been shown that
most miscarriages resulting from uterine defects occur in the second trimester [37].
1.3.3.5 Reproductive and endocrine disorders
Women with disorders dealing with their menstruation including polycystic ovarian
syndrome (PCOS), endometriosis, luteal phase defects and others have all shown to
carry a higher risk of miscarriages [35]. Women with PCOS, a very common endocrine
disorder, often have issues with conception including anovulation and infertility. There
is a clear association between PCOS and any type of loss (sporadic, and recurrent).
Between 4% to 82% of women with miscarriages have been shown to have polycystic
ovaries on ultrasounds [40]. Women with endometriosis often have embryos that have
decreased ability to implant, thereby increasing recurrent miscarriage [41].
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1.3.4 Recurrent Miscarriage
A recurrent miscarriage, by definition, is the history of having more than one
miscarriage. Recurrent miscarriage occurs in approximately 1-3% of women. This rate
belongs to a specific type of definition of recurrent miscarriage (RM) which is defined
by three or more previous consecutive pregnancy losses [42].
One of the issues with RM is its terminology on the classification of RM. Globally,
the definitions are varied and diverse. The American Society of Reproductive
Medicine sometimes defines it as two non-consecutive losses meaning any two or
more losses in the span of the reproductive career of the woman. The Danish Society
of Obstetrics and Gynecology, European Society of Human Reproduction and
Embryology, National College of French Gynecologists and Obstetricians and the
Japan Society of Obstetrics and Gynecology all define RM as three consecutive losses.
There also seems to be a difference in whether a loss is verified via histology or scans.
The distinctions are described in Table 1.
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Table 1: Different definitions of RM by different organizations around the world
Definition
Two or more
consecutive
losses

Organization
1. American Society of Reproductive
Medicine [43]
2. European Society of Human
Reproduction and Embryology
(ESHRE)*[44]

Remarks
*
ESHRE had two definitions
but has concluded that
defining RM as two or more
pregnancy losses will
facilitate research, shared
decision-making, and
enhance the psychological
support available to couples
**
Three or more 1. Danish Society of Obstetrics and
The Danish Society
consecutive
Gynecology**
requires at least one of the 3
losses
2. European Society of Human
to be a verified miscarriage
Reproduction and Embryology* [45] ***The French college terms
3. National College of French
it as miscarriages before 14
***
Gynecologists and Obstetricians
weeks of gestation.
4. Japan Society of Obstetrics and
Gynecology
Any two or
1. Dutch Society of Obstetrics and
Must be verified
more losses
Gynecology [46]
miscarriages
Any three or 1. Royal College of Obstetrics and
It includes miscarriages
more losses
Gynecology (UK) [47]
before viability
As described in Table 1, RM has different nomenclature which complicates the
uniform understanding of its effects pertaining to its prevalence and incidence.
However, despite the differences in the number of consecutive-ness of its occurrence
or whether it was verified, RM is factored by some characteristics.
1.3.4.1 Causes of RM
As the research covered in this dissertation does not go into detail about the factors
that might cause RM, the discussion regarding the reasons for RM will be kept brief.
Most reasons for miscarriages, recurrent loss or not, often tends to be genetic,
hormonal, and anatomical. All the causes for sporadic miscarriages specified above
from sections 1.3.3.1 to 1.3.3.5 have been shown to be associated with RM as well.
Consequently, miscarriages, both sporadic and recurrent, have also been shown to be
associated with anesthetic agents [40], smoking, alcohol, and caffeine [41]. There are
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multiple reasons to why RM might affect some women and not others. Although a
significant number of women who experience RM will have no reason attributed to
them [48], there are some characteristics that are specifically associated with RM that
will be outlined below. For instance, maternal age and the number of previous
miscarriages have been noted as the main predictors of RM [28]. The reasons why
these two associations persist is due to oocyte or egg and embryonic aneuploidy [49]
and also because of the less receptiveness of the endometrium [50]. The effects of age
on sporadic and recurrent losses of pregnancy are shown in Figure 2 as suggested by
Rai et al. [13]. It is shown that with increasing maternal age, the frequencies of
recurrent losses are higher than that of sporadic losses. The effect of paternal age is
not well documented but some disorders that are autosomal dominant like trisomy does
tend to increase with paternal age [51].

Figure 2: Image depicting types of loss based on maternal age. Adapted from Rai et
al. [13]
Consanguinity has also been associated with miscarriages [42]. Additional biological
reasons are described in Table 2. Random events such as infections also play a part in
the cause of RM. If a woman had a history of RM that can only be attributed to random
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events such as infections, it is likely that the RM is not associated with underlying
pathologies of the woman. However, regardless of the reason for the advent of it, RMs
have been associated with poor outcomes in the mother and future children.

Table 2: Clinical reasons for the diagnosis of recurrent miscarriage around the world
Reason for RM
Anti-phospholipid
Syndrome (APS) or
Hughes Syndrome
[52]

Endocrine defects
[53]

Parental
chromosomal
abnormality [53]

Trisomy or
monosomy [53]

Explanation
Identified rates
The most treatable source of RM 15% of all RM cases have
is APS. Clinical studies report that shown some inclination
anti-phospholipid impairs the
towards APS. Women with
mechanism controlling
APS are also shown to
endometrial cell changes.
have a miscarriage rate of
Furthermore, APS increases
90%.
trophoblast apoptosis, decrease
fusion and impair invasion.
Endocrine defects most commonly Luteal phase defects have
are due to luteal phase defects
been shown to be present
because of a lack of progesterone in 23 to 60% of RM cases.
secretion of the corpus luteum.
40% of women with RM
Polycystic ovarian syndrome
have been diagnosed or
(PCOS), an endocrinological issue will be diagnosed with
itself, has shown to affect insulin PCOS.
resistance which in turn leads to
pregnancy loss.
Karyotype abnormalities in the
Between 3 to 5% of RM
parents have been shown to lead cases are due to parental
to unbalanced embryos during
chromosomal
pregnancy. In-vitro fertilization
abnormalities.
seems to be the best treatment for
those affected.
Fetal aneuploidy is the most
About 30% of all
common reason for all type of
miscarriages are tri-somic
miscarriages spontaneous or
while another 10% are due
recurrent. Some women with RM to either sex chromosome
have shown more possibility of
mono-somy or polyploidy.
hetero-trisomy (recurrence of a
different trisomy subsequent to a
trisomic pregnancy).

1.3.4.2 Outcomes associated with RM
Pregnancy loss or miscarriage is often referred to as an invisible loss as the event
may not be publicly acknowledged [54]. Hence, research which looks at pregnancy

14
loss tends to pay attention to increasing the rates of live births in couples with RM
[45]. However, RM has other adverse outcomes associated with its advent other than
future miscarriages. The success of a future pregnancy in producing a live birth is the
most common outcome of RM that most researchers are interested in, as suggested
above [55] as women with previous losses are more likely to have future threatened
miscarriages [56]. The odds of having a miscarriage increases upon having one than
none. It follows a linear path where the risk of miscarriage is greater following two
miscarriages than in pregnancies following one miscarriage [57]. This seems to be the
theme when it comes to stillbirth as well. The risk of stillbirth in subsequent
pregnancies is higher when there is a history of stillbirth [58].
Maternal history of recurrent miscarriage is associated with a higher risk of future
pediatric neurological morbidity of the offspring [59]. Women with a history of RM
have been shown to have higher rates of preterm delivery, small for gestational age
babies and perinatal losses [59]. They are also more at risk of cesarean section
deliveries, cervical incompetence, diabetes mellitus, hypertensive disorders, placenta
previa and placental abruption [60]. RM has also shown to be an independent risk
factor for maternal cardiovascular complications. This includes the need to perform
diagnostic procedures for those complications, either invasive or noninvasive [61].
RM has shown to increase the number of cardiovascular hospitalizations as well.
Women with a history of miscarriages have also been shown to face a higher risk of
pre-eclampsia, induced labor, instrumental delivery, preterm delivery and low birth
weight babies [56].
Perhaps one of the most predictable outcomes of pregnancy loss in general is grief.
The loss of a pregnancy or baby has been identified as major life event with the
possibility of long-term traumatic effects [62]. This will not be discussed in detail here
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as this work was not able to test for the associations between mental health and a
history of RM due to lack of data.
It is evident from the information above that a history of RM can lead to poor outcomes
in both the mother and the child. To understand the effects of RM, there is a need to
study women with such a history in a systematic way.
Similarly, a history of RM might also influence the lifestyle of women in their future
pregnancies. However, the effect that multiple miscarriages have on future pregnancy
actions is relatively unknown [63]. Such women might undertake better lifestyles such
as initiating antenatal care earlier [64] or poorer lifestyles such as smoking [65].
Women with a history of miscarriage are sometimes followed up during their future
pregnancies to describe and understand lifestyle factors such as their coping behaviors
and depressive symptoms [66, 67]. Nevertheless when looking at other lifestyle
changes, one study has shown that a history of miscarriages has not been shown to
improve pregnancy behaviors such as alcohol consumption, multi-vitamin usage or
meeting exercise requirements in women who experience them as compared to women
with no such history [63]. Thus, this background knowledge further reiterates the need
to understand and observe the lifestyle of women with a history of RM in their future
pregnancies.
1.3.4.3 Chronology of RM
The chronology or timing of occurrence of RM is also a relevant factor in the future
of women with a history of RM. A women with a history of RM is considered to have
primary RM when all of her previous pregnancies have not been successful or viable
and did not lead to a live birth [68]. If the woman has had a successful pregnancy or a
live birth between her miscarriages, it is considered as secondary RM [68]. Based on
recent literature, it is not apparent whether primary or secondary RM tends to increase
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risks in women for future pregnancies [59, 69, 70]. Shapira et al. have also found that
the rates of future successful pregnancies and deliveries between the two types of RM
have been similar as have Clifford et al. [68, 71]. There is a need for the systematic
evaluation between these two groups of RM based on their chronology of occurrence
to understand how best to investigate them and follow them up. Well-designed cohort
studies pave the way for such robust research on RM.
1.3.4.4 Importance of cohort studies in RM
Birth cohort or maternal and child cohort studies play a significant role in the
investigation of the health and disease during pregnancy, delivery, early and late
childhood. Such cohorts have been established in many places around the world
including the Avon Longitudinal Study of Parents and Children [72], Danish National
Birth Cohort [73] and the Norwegian Mother and Child Health Study (MoBa) [74].
Some of these studies like the MoBa have had some foray into the RM literature [75].
However, there is still a lack of robust data on RM from prospective cohort studies
globally as well as locally in the UAE and its surrounding region. Earlier studies on
RM have recruited small non-representative samples of women with RM from
European, North American, and South Asian populations with limited data on Middle
Eastern or Arab populations. Only one study has been conducted in the UAE about
RM and found that women with a history of RM wanted support and affirmation after
their losses [76]. Other research within the region on RM is scarce with general focus
on biochemical processes of RM [77-79]. Furthermore, longitudinal studies observing
the trends and patterns of RM are few. Such studies are needed not only to
systematically understand the history of RM by retrospectively reviewing medical
records or asking the participants to recall, but also to prospectively view the impact
of RM on their obstetric health. Checking the chronology of the RM is also necessary
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which is not constructively possible without a well-designed cohort study. Cohort
studies with both retrospective and prospective data would allow for researchers to
understand the history of loss, its etiology and its effects in a rigorous manner.
There is also a lack of studies in the Gulf Cooperation Council on exposures such as
RM. A systematic review done recently has shed light on the topics mostly
concentrated on by researchers in the region. While maternal and child health research
is being conducted here, exposures seem to mass around maternal and medical factors
such gestational diabetes mellitus and maternal obesity. Only one study in the
systematic review had some venture into RM [80].
Therefore, population-based studies with longitudinal designs are required to assess
the epidemiological burden of RM and its influence on maternal health outcomes. With
all these in mind, this research aims to systematically understand women with a history
of RM and their future outcomes upon future pregnancies using a prospective
longitudinal cohort study on pregnant women.
1.4 Study Objectives
This doctoral research project aimed to explore the epidemiology of RM in pregnant
women in the UAE. As the RM definitions vary and there is no definition used
extensively in the UAE, this work explores RM using four different definitions. Each
definition will be considered as an exposure. The socio- demographic characteristics
and the effects on the behaviors of women during their index pregnancy will be
examined for each of the exposure definitions. Furthermore, the project will identify
the outcomes of women with a history of RM in terms of maternal and fetal outcomes.
The main dependent variables (behaviors in index pregnancy and outcomes in index
pregnancy) will be assessed. Lastly, the differences on when the RM occurred and its
effect on the socio-demographics of the participant at this index pregnancy will be
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investigated. Hence, the effect of primary RM and the effect of RM that occurs right
before the index pregnancy and its effects on the behaviors of the women and the
outcomes at pregnancy will be explored.
The main objectives of the thesis are to:
1. Estimate the rate of RM in a population of Emirati pregnant women
2. Describe and compare the characteristics of pregnant women with history of RM
to those with no history of RM
3. Investigate the associations between history of RM and behavior of women during
future pregnancies
4. Investigate the associations between history of RM and maternal and birth
outcome of future pregnancies
5. Investigate the effect of chronology of RM on future behavior and pregnancy
outcomes
1.5 Study Hypothesis
It is hypothesized that:
1. The proportion of RM in this population of pregnant women might be higher than
that of global metrics (1-5%).
2. Women with history of RM would have better behaviors as compared to women
who do not experience RM to ensure healthy pregnancies and deliveries.
3.

Women with history of RM will experience a significantly higher number of
adverse outcomes in their index pregnancies compared to women with no history
of RM.

4. The chronology of RM occurrence in the reproductive career of pregnant women
will influence index pregnancy behaviors and outcomes.
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Chapter 2: Methods

The dissertation is based on the Mutaba ah Study, a longitudinal cohort study currently
ongoing in the UAE. Firstl , the Mutaba ah Stud will be described before the detailed
description of the components most related to this dissertation which will henceforth
be called as the RM study.
2.1 The M aba ah S d
2.1.1 Study Design
Mutaba ah, (meaning follow up in Arabic), the Mother and Child Health Stud is a
large prospective cohort study currently recruiting participants in Al Ain city [81]. It
aims to recruit 10,000 mothers and baby pairs with each pair suggesting a pregnancy,
and to follow the children until the age of 16 years. The study will secure
epidemiological data on maternal and child health to investigate the health and
maternal outcomes of the mother, and the maternal and early-life determinants of
infant, child and adolescent health.
2.1.2 Study Setting
Al Ain is the second largest city in the Emirate of Abu Dhabi (the largest UAE emirate
in terms of land mass and population size) and has the largest and relatively stable
population of Emirati citizens compared to other parts of the country. This makes it an
ideal setting for a birth cohort study with longitudinal follow-ups. In 2016, the Emirate
of Abu Dhabi population was estimated to be approximately 2.9 million, of which,
approximately 19% were Emiratis and around 41% of these Emiratis lived in the Al
Ain region [82]. The population of Al Ain was approximately 766,900 (mid-2016) of
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which 226,300 were Emirati citizens and of these 53,995 were women of reproductive
age (15-44 years) [82]. Levels and standards of antenatal care are high, and all births
take place in hospital. Although the Mutaba ah Stud has the potential to expand to
involve many health institutions, the initial recruitment has been confined to three
major hospitals in Al Ain: the only two public hospitals and one large private hospital;
Al Ain Hospital, Tawam Hospital, and Oasis Hospital, respectively. As all of the
Emirati population has full health insurance allowing them to have the same level of
health care at any health facility, there is no difference in health care access between
pregnant women attending these three hospitals and those who use other institutions.
Therefore, a representative sample of the Emirati population in Al Ain can be recruited
from these three hospitals.
2.1.3 Inclusion Criteria
Invitation for participation was limited to the Emirati population. All pregnant women
from this population attending any of the three participating hospitals for their
antenatal care management who are at least 18 years old, resident in Al Ain, ideally in
their first trimester (approximately 12 weeks of gestation), able to provide informed
consent, and their newborns were eligible to be included in the study. Women with
multiple pregnancies (pregnant with more than one fetus) and those who conceive
multiple times during the study period, as well as their offspring were also eligible to
be included in the study so long as they provide consent.
2.1.4 Exclusion Criteria
The study excluded expatriates as they are less likely than the Emirati population to be
available for long-term follow-up. Pregnant women younger than 18 years or those

21
who are unable to provide consent and women who are not currently pregnant, were
also excluded.
2.1.5 Sampling and Recruitment
There are approximately 6,600 births of Emirati children each year in Al Ain, of which,
the clear majority take place in the three participating hospitals. The study employs a
consecutive sampling strategy whereby all eligible pregnant women that present at any
of the three hospitals were invited to participate in the study. Eligible participants were
identified via a health care provider (nurse or ph sician) at each hospital s registration
point and were approached by an on-site research assistant with an information sheet
detailing the project. If they expressed interest, participants provided informed
consent. This consent allows for follow-up interviews and the extraction of their and
their babies health information from medical records up until the child is 16 years old.
The study was conducted in accordance with the principles of the Declaration of
Helsinki. Each participant has the right to withdraw from the study at any time without
giving any reason. During enrolment, the participant was provided with a detailed
information sheet on the Mutaba ah stud

description, contact details (telephone

number and email address), and the withdrawal process. In addition, the withdrawal
process was explained verbally to the participant. The participant was informed
verbally and in writing that they can call or email at any time to execute their right to
withdraw from the study. Should a participant wish to withdraw from the study, and
wish for their collected data to be destroyed, this will be completed in a prompt and
secure manner and a message will be sent to the woman to confirm study withdrawal.
The reason for withdrawal, if given, will be recorded in the database. Participants
provided input during their recruitment process on their thoughts on how best to follow
them and their children up after delivery, and how to access more participants. This
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information was usually collected verbatim by the data collectors or collected via
administrative forms. Participants were not consulted about study outcomes or
interpretation of the results.
2.1.6 Data Sources and Measurements
Collected data included but was not limited to: demographic, socioeconomic, lifestyle,
environmental, education, employment, physical and mental health, household and
family information, parental health, social support, local community and services,
mother and child nutrition, previous pregnancies and birth outcomes, health and
development of child, and childcare information.
Data is collected around the following time points: 12 weeks of gestation; 25 weeks of
gestation; at the time of delivery; and at six and 12 months for the infants. Further time
points for follow-up during childhood and adolescence will be decided later.
In addition to data abstracted from the medical records (MR), data is obtained using
three tablet-assisted self-administered questionnaires: a short questionnaire (SQ), long
questionnaire (LQ), and a food frequency questionnaire (FFQ). Appendix B shows
examples of the types and sources of data collected during the study. The SQ is
administered at the first point of contact and comprises 67 questions on varying sociodemographic and psychosocial measures. Questions were pooled and adapted from the
Avon Longitudinal Study of Parents and Children [72], the Norwegian Mother and
Child Study [74, 83], the Danish Birth Cohort Study [73], and the Born in Bradford
study [84]. The LQ is a combination of questions asked in the four cohort studies
previously mentioned that were used to develop the SQ as well. However, it delves
deeper into psychosocial dimensions of health including mental health using scales
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such as the Edinburgh Depression Scale [85] and the Spielberger State Trait Anxiety
Inventory [86].
All questionnaires were translated from English to Arabic by one group of study
researchers and then back translated from Arabic to English by a different group of
study researchers. The LQ was not used for the purposes of this thesis, as the women
who delivered at the time of writing did not have a sufficient pool of responses in the
LQ.
Clinical data was abstracted by the research team using a standardized chart abstraction
tool (Appendix B) to ascertain pre- and perinatal conditions, anthropometrics of both
mother and child, delivery and birth outcomes, and childhood diseases. Medical
records of the mother provided information on the progress of the pregnancy and
pregnancy outcomes. Information was extracted from the laboratory test and imaging
results which are performed routinely on all women. These routine antenatal care
screening and tests include among others, complete blood count, vitamin D (plasma
25-hydroxyvitamin D3), infectious disease screening (i.e. hepatitis B virus, human
immunodeficiency virus, rubella, syphilis, varicella), cervical cancer screening,
haemo-globinopathy screening, anomaly scan, gestational diabetes mellitus screening,
and repeated measures of proteinuria, fetal growth, heart tones, fundal height
measurements, maternal body mass, body mass index, and blood pressure. All medical
outcomes are ascertained from the woman s and child s medical records as
standardized definitions are employed following the regulations and guidelines of the
Department of Health of Abu Dhabi [87]. Official birth notification and delivery
records provided data on the delivery and birth outcomes. Important information on
genetic exposures and outcomes are collected from the medical records and
questionnaires. Examples of genetic data include degree of consanguinity, family
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history of diseases, and routine genetic screening results of the mother and child such
as thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait.
No biological samples are collected at this stage of the study. The full protocol of the
Mutaba ah Stud can be found elsewhere [81].
This thesis only uses the medical record extraction at delivery as well as the SQ for
the analyses to be discussed later. While the consequences of pregnancy loss can be
continuous and last longer than at the period of loss, this was not the interest of the
current dissertation. However, it is indeed necessary to mention that pregnancy loss
and its consequences on the mother, father and future children will be of great interest
to the Mutaba ah stud team and are a focus of questionnaires and medical record
extractions at future time points.
2.1.7 Ethics
Ethical approvals have been granted by the United Arab Emirates University Human
Research Ethics Committee (previously known as Al Ain Medical District Human
Research Ethics Committee) (ERH-2017-5512), Al Ain Hospital Research Ethics
Committee (AAHEC-03-17-058) and Tawam Human Research Ethics Committee (THREC 494). Informed written consent is obtained from the participant prior to the
data collection.
2.2 The RM Study
This section describes the data, variables and measurement of information specifically
important to this dissertation.
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2.2.1 Data Sources and Manipulation
Questionnaire data:
Information about the participants employment, education, previous infertility
treatment, whether the index pregnancy was a planned pregnancy, sedentary behavior,
physical activity, consanguinity, total people living in household, anxiety about birth,
perceptions of social support, gestational age at recruitment (in months), self-reports
of previous diseases such as gestational diabetes mellitus (GDM) and previous birth
complications such as miscarriages, stillbirth, low birth weight babies and preterm
babies were extracted from the questionnaires database. Planned pregnancy was coded
as

es or no . Consanguinit was coded as

es or no while women who had

reported I don t know or Related via tribe were not included in the variable. The
total number of people living in the household was summed up by 4 different variables
including the number of children less than 6 years old, children between 6-12 years,
people between 12 and 18 year and adults above 18 years of age. Gestational age was
reported in months. Reporting of fertility treatment, previous GDM and birth
complications were all coded as

es or no . Responses of I don t know were not

included in the binary variables. Antenatal care initiation was determined using the
question: Is this our first antenatal visit for this pregnanc ? with the options being
Yes or No . A new dichotomous variable Appropriate Initiation and Late
Initiation

was created based on international pregnancy guidelines for appropriate

ANC initiation: Appropriate Initiation were women who had their first ANC visit
during or before the first three months of gestation (first trimester) and Late Initiation
were women who had their first ANC visit after four months of gestation.
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Folate use was recorded as

es or no response to whether the participant was

consuming folate daily, weekly or monthly during and before her pregnancy. Daily
folate use (yes/no) was considered as the primary variable for folate consumption as
this is the recommended frequency of consumption. Contraceptive use was also
extracted from the SQ. If the woman had recorded that she did not use any
contraception, she was labeled as no contraceptive use while any other choice of use
of contraception was labeled as contraception use. While participants reported
smoking habits using the responses never , occasionall

or regularl , all smoking

questions were recoded as binary variables (yes and no). Women were queried on their
anxiety towards childbirth and the factor worrying about birth was labeled as a
should the have answered Yes, quite a lot or

es

es, sometimes and no if the had

answered No, not at all and no, not much . Similarl , social support was labeled as
es if the respondent answered

es, enough and

es, definitel enough and was

labeled as a no if the respondent answered as no, not much or no, not at all .
Physical activity was reported in the questionnaire as women who had been active in
frequency bouts of never, 1-2 times a week, 3-5 times a week or daily in the last three
months of the pregnancy as well as during the pregnancy. For simplicit s sake, it was
coded as ever if woman had reported an thing other than never for with periods of
her life and never if she had chosen never as her response. Furthermore, to
understand activity, a question on sedentary behavior was administered on how long
the women sat during the weekdays and weekends. The number of hours spent sitting
was kept continuous.
Medical records data:
Information of the pregnancy losses were extracted from the medical records. All
previous pregnancies were ordered chronologically and coded as lost or not lost .
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Consecutive losses were calculated if for instance, the first and second pregnancy were
losses or the second and third pregnancy were losses and so on for two consecutive
losses. A similar approach was adopted for three consecutive losses as well. Once all
pregnancies were coded as being losses or not, they were summed to count the total
number of losses. Women needed to have at least two or three previous pregnancies to
be used in any of the four definitions of RM. For the definition of any losses, the total
numbers of losses were used. If a woman had a gravidity of two or three or more
pregnancies, and a total loss of two or three or more respectively, she would be coded
as having a history of two or more losses or three or more losses.
The definitions of the four different diagnostic measures of RM are as below:
1. Two or more consecutive losses when the woman has been reported to have
experienced two losses one after another simultaneously at least once during
her reproductive career.
2. Two or more losses - when the woman has been reported to have experienced
any two losses or more during her reproductive career whether they were
consecutive or not.
3. Three or more consecutive losses- when the woman has been reported to have
experienced three losses one after another simultaneously at least once during
her reproductive career.
4. Three or more losses - when the woman has been reported to have experienced
any three losses or more during her reproductive career whether they were
consecutive or not.
Furthermore, the chronology of RM was investigated by creating composite variables
for primary RM and immediate RM. Using two consecutive losses as the main
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exposure of RM, if a woman had a history of RM at the beginning of her reproductive
career, she was labeled as having a history of primary RM. In other words, a woman
with consecutive losses in her first and second pregnancy would be labeled as a woman
with primary RM. Additionally; a woman would be labeled as having immediate RM
if her two consecutive cases occurred immediately prior to this current pregnancy. In
other words, if the current pregnancy was her nth pregnancy, a woman will be labeled
as having a history of immediate RM if her n-1th pregnancy and n-2nd pregnancy were
consecutive losses.
Age was extracted from the medical records of the women and is the number of years
that had surpassed from the time of birth to delivery of the index pregnancy. When not
available, age was deduced from the national identification document (Emirates ID)
and was calculated using the year of birth and the year of recruitment or delivery. In
this doctoral work, numbers of pregnancies include all successful and non-successful
viable pregnancies that were recorded by the hospital. Information about the pregnancy
progression, anthropometric measures, delivery and labor data as well as newborn data
was also extracted. The first maternal body mass and blood pressures measurement
were the first ever recorded measure, respectively, for the current index pregnancy
available in the medical records. Inter-pregnancy interval was calculated of the most
recent previous pregnancy and the index pregnancy using the following formula:
Inter-pregnancy interval = Delivery date of index pregnancy
immediate previous pregnancy

Delivery date of

gestational age of index pregnancy

Outcomes of pregnancy were all labeled as ICD codes (ICD 10) in the medical record
extraction. A separate variable was created with a dichotomous label (yes or no) to
indicate if the women or neonate suffered or was exposed to the outcome of interest.
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For example, if the woman was coded to have O24.419, she will be coded as having
gestational diabetes mellitus (GDM). Other women who have had entries in their
diagnosis and have delivered but do not have the code were coded as no GDM. Women
with previous type 1 and type 2 diabetes would not be coded as having GDM. Preterm
birth was calculated using the cut-off of 37 weeks at birth. Very preterm birth was
coded yes or no if the child was born before the 32nd week of gestation. Blood loss
during delivery was provided in milliliters and divided by the standard deviation
during regression analysis. The length of stay hospital (days) was often provided by
the hospital records. If length of hospital stay was not provided in the medical records,
then it was calculated (in days) using the time stamp of admission and discharge from
hospital. All birth weights of children were provided in grams. For easier analyses,
birth weight was divided by standard deviation during regression. NICU admission
was coded as a yes or a no.
2.2.2 Sample Size
Assuming an exposure level of 10% (a history RM) and an outcome of 30% (Cesarean
section) in the unexposed group, a cohort of 1700 pregnancies will allow the detection
of approximately 1.6 odds association in the exposed group relatively to the unexposed
group with 80% power and a 5% Type I error probability. Accounting for a 20%
attrition rate to the follow up of these women at delivery, a cohort size of 2,040 will
allow for the detection of an increased proportion of outcomes in the exposed group
(history of RM) by 20%. This is according to the Fleiss method of sample size
calculation for cohort studies [88].
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2.2.3 Statistical Methods
Crude prevalence and incidence of key outcomes were estimated. Descriptive statistics
was performed to show the distribution of the study population characteristics for the
different definitions of loss. Continuous variables were presented as means with
standard deviations, while categorical variables were presented as counts
(percentages). Continuous variables with a normal distribution were compared using
a Student t-test or analysis of variance (ANOVA). Categorical data was compared
using the Pearson Chi-square test. The four definitions or RM were treated as
individual as main exposure variables. The definition of 2 losses was used to stud
the differences in chronology of the RM and its effects on characteristics, behaviors
and outcomes in the index pregnancy. Univariate and multivariate regression models
were used to quantify the association between potential exposures (either the different
diagnostic definition of pregnancy loss or chronology) and the different outcomes.
Logistic and linear models was be used for binary and continuous outcome variables,
respectively. Crude and adjusted odds ratios with 95% confidence intervals are
reported. Statistical analyses were performed using Stata 16 (Stata Corp, College
Station, TX). P value 0.05 will define statistical significance.
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Chapter 3: Results and Findings

3.1 Overall Population

A total of 2,769 women were part of the analysis of this dissertation. Despite more
than 7000 women being recruited to the Mutaba ah Stud at the time of submission,
only 2,769 had successfully delivered (or lost to follow up) and had medical record
data of their delivery available at the time of the writing of this dissertation. 42.1%
(n=1,167) were recruited in Tawam Hospital while 33.9% (n=938) were recruited in
Kanad Hospital (previously known as Oasis Hospital) and 24.0% (n=664) of these
women were recruited in Al Ain Hospital. The average age of these participants was
30.6 ± 6.0 years at recruitment. For the index pregnancy, the participants were
recruited at any gestational age during their pregnancy. The average gestational age at
recruitment was 6.2 ± 2.3 months. Furthermore, the average number of pregnancies or
gravidity per woman was 3.6 ± 2.2 while the average parity or number of children was
3.0 ± 1.8. A total of 542 women (19.6%) were primi-gravida and hence, were not
included in the analyses as they had no previous pregnancies. The distribution of
gravidity (which excludes the index pregnancy and delivery) is illustrated by the
Figure 3.
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Figure 3: The distribution of number of pregnancies (gravidity) in the study
population
Amongst the remaining 2,227 women who have been pregnant before, a total of 766
(34.4%) of them would have had at least one loss. The variations in loss are illustrated
in the table below (Table 3).

Table 3: The frequencies of loss in the 2,227 pregnant women with at least one
previous pregnancy prior to index pregnancy in the Mutaba'ah study in Al Ain, Abu
Dhabi
Total losses
No miscarriage
One miscarriage
2 miscarriages
3 miscarriages
4 miscarriages
5 miscarriages
6 miscarriages
7 miscarriages
9 miscarriages
10 miscarriages
Total

Number of participants with history of
miscarriages
1,461
511
149
62
27
10
4
1
1
1
2,227

Percentage
65.6
23.0
6.7
2.8
1.2
0.4
0.2
0.04
0.04
0.04
100.00
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The distribution of population characteristics of women who had experienced any loss
versus no loss is presented in Table 4. The findings show that women with any loss
were older, more parous and were more likely to have had infertility treatment. They
were also more likely to have reported a previous low birth weight baby or a preterm
birth. All these differences were statistically significant. With regards to behaviors,
women with a history of loss were more likely to consume folate prior to their index
pregnancy (21.3% versus 13.9%, p<0.001) and not consume contraceptives prior to
the pregnancy (56.5% versus 48.4%, p<0.001). Women with a history of loss were
more likely to deliver via cesarean section (27.7% versus 20.7%, p<0.001) during the
index pregnancy and have preterm births (11.3% versus 7.2%, p=0.002).

Table 4: Characteristics of 2,227 pregnant women (no history of loss compared to
those with at least one loss) in Al Ain, UAE

Age (years)
Gestational age at recruitment
(months)
Number of pregnancies
Planned pregnancy
Yes
No
Worrying about birth
Yes
No
Social support
Yes
No
Education
High school and below
Diploma and above
Employment
Employed
Unemployed/Student
Number of people living in home
Previous Gestational Diabetes Mellitus
Yes
No

No loss
(n=1461, 65.6%)
30.9±5.4

At least one loss
(n=766, 34.3%)
32.9±5.9

p-value

6.3±2.2

6.0±2.3

0.0014

3.5±1.7

5.5±2.4

<0.0001

680 (49.6%)
691(50.4%)

360(50.1%)
358(49.9%)

0.814

<0.0001

0.878
896(65.9%)
463(34.1%)

469(65.6%)
246(34.4%)

1222 (89.7%)
140 (10.3%)

636 (88.9%)
79 (11.1%)

0.587
0.416
841(60.9%)
539(39.1%)

455(62.8%)
270(37.2%)

476(34.6%)
900 (65.4%)
12.1±8.3

276(38.3%)
445 (61.7%)
11.6±7.4

385(28.2%)
981(71.8%)

229(32.1%)
485(97.9%)

0.094
0.1993
0.065
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Table 4: Characteristics of 2,227 pregnant women (no history of loss compared to
those with at least one loss) in Al Ain, UAE (continued)
No loss
(n=1461, 65.6%)
Consanguinity
Yes (via parents)
562(47.4%)
No
625(52.7%)
Previous infertility treatment
Yes
99(7.3%)
No
1263 (92.7%)
Previous low birth weight baby
Yes
493 (39.0%)
No
771(61.0%)
Previous premature baby
Yes
198 (15.0%)
No
1120 (85.0%)
Folate usage before index pregnancy
Daily
169 (13.9%)
Not daily
1,043 (86.1%)
Contraceptive use
Any
711 (51.6%)
None
667 (48.4%)
Physical activity during pregnancy
Any
388 (50.1%)
None
387 (49.9%)
Smoking during index pregnancy
Yes
12 (0.9%)
No
2 (0.3%)
Cesarean section in index pregnancy
Yes
302 (20.7%)
No
1,159 (79.3%)
Gestational Diabetes Mellitus
Yes
331 (25.0%)
No
994 (75.0%)
Preterm birth in index pregnancy
Yes
91 (7.2%)
No
1,181 (92.1%)
Blood loss in milliliters during index
363.6±274.7
pregnancy (ml)

At least one loss
(n=766, 34.3%)

p-value
0.250

280(44.5%)
349 (55.5%)
<0.0001
112 (15.8%)
595 (84.2%)
<0.0001
288(49.3%)
296(50.7%)
<0.0001
145 (23.8%)
465 (76.2%)
<0.0001
143 (21.3%)
527 (78.7%)
<0.0001
321 (43.5%)
417 (56.5%)
0.741
216 (51.1%)
207 (48.9%)
0.115
1,389 (99.1%)
726 (99.7%)
<0.0001
209 (27.3%)
557 (72.7%)
0.476
167 (23.6%)
542 (76.5%)
0.002
76 (11.3%)
597 (88.7%)
390.6±308.0

0.147

Missing data were excluded from the calculation of proportions and means presented for each variable;
mean and standard deviation.

The prevalence of RM based on the four different definitions was calculated among
1737 women with at least gravidity of two or more for the first two definitions and
among 1316 women with at least a gravidity of three or more for the third and fourth
definitions (Table 5). The highest proportion of RM was for those suffered any two or

35
more losses (14.7%) and the lowest proportion was for those who suffered consecutive
three or more losses (5.8%).

Table 5: Proportions of pregnant women who had a history of RM based on four
definitions
RM definitions
Women with consecutive two or more losses
Women with any two or more losses
Women with consecutive three or more losses
Women with any three or more losses

Yes
N (%)
234 (13.5)
255 (14.7)
76 (5.8)
106 (8.1)

No
N (%)
1,503 (86.5)
1,482 (85.3)
1,240 (94.2)
1,210 (91.9)

Total
1737
1737
1316
1316

3.2 Characteristics of Women with Pregnancy Loss Based on Different
Definitions

For both definitions 1 (consecutive 2 losses) & 2 (an

2 losses), women with RM

were slightly older, more parous, and more likely to have had infertility treatment
previously. The mean (±SD) age of women with a history of RM was 33.7 ± 5.6 years
compared to 32.6 ± 5.2 years in women without a history of RM. In general, women
with a history of RM had on average two more children than those without a RM
history (mean ± SD gravidity 6.2 ± 2.6 versus 4.0 ± 2.0, respectively). More than a
fifth (22.1%) of women with RM reported that they had undergone previous infertility
treatment compared to 8.1% of those without a history of RM. There were no
significant differences in the planning status of the current pregnancy, education, or
consanguinity between the two groups (p>0.05). The characteristics of women in the
two different diagnostic definitions for two losses are illustrated in Table 6.
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Table 6: Characteristics of pregnant women with gravidity of two or more according
to their history of recurrent miscarriage (RM) status (consecutive or any loss) in Al
Ain, Abu Dhabi

N (%)
Age (years)
Gestational age at
recruitment (months)
Number of pregnancies
Worrying about birth
Yes
No
Social support
Yes
No
Education
High school and
below
Diploma and above
Employment
Employed
Unemployed/Student
Number of people living in
home
Previous Gestational
Diabetes Mellitus
Yes
No
Consanguinity
Yes (via parents)
No
Previous infertility
treatment
Yes
No

Consecutive
2 losses
No losses
234 (13.5%) 1,503
(86.5)
33.7+5.6
32.6+5.2
5.8+2.3

6.3+2.3

6.2+2.6

4.0+2.0

Any
p-value

2 losses
255 (14.7)

No losses p-value
1,482 (85.3)

0.005
0.005

35.3+5.3

32.3+2.1

<0.001

5.8+2.3

6.3+2.3

0.007

<0.001 7.1+2.4
3.8+1.9
0.120
152 (68.2%) 875 (62.7%)
158 (65.0%) 869 (63.2%)
71 (31.8%) 519 (37.2%)
85 (35.0%) 505 (36.8%)
0.352
1,244
1,227
194 (87.0%)
211 (86.8%)
(89.1%)
(89.2%)
29 (13.0%) 152 (10.9%)
32 (13.2%) 149 (10.8%)
0.777
137 (61.7%) 891 (62.7%)
85 (38.3%)

530 (37.3%)

83 (34.0%)

96 (43.1%) 525 (37.1%)
127 (56.9%) 889 (62.9%)
12.2+8.1

0.286

0.232

161 (66.0%) 867 (62.0%)
532 (38.0%)

0.09

11.5+7.7

<0.001
0.596

0.662
96 (39.2%) 525 (32.7%)
149 (60.8%) 867 (62.3%)

0.230

11.7+7.3

12.2+8.1

0.408
78 (35.6%) 462 (32.8%)
141 (64.4%) 947 (67.2%)

0.470
0.08

92 (38.0%) 448 (32.3%)
150 (62.0%) 938 (67.7%)
0.401

84 (44.0%) 582 (47.2%)
107 (56.0%) 650 (52.8%)

0.623
95 (45.2%) 571 (47.1%)
115 (54.8%) 642 (52.9%)

<0.001

<0.001

48 (22.1%) 112 (8.1%)
50 (20.8%) 110 (8.1%)
1,276
1,255
169 (77.9%)
190 (79.2%)
(91.9%)
(91.9%)
Missing data were excluded from the calculation of proportions and means presented for each variable;
mean and standard deviation.

The characteristics of women based on definitions 3 (consecutive 3 losses) & 4 (an
3 losses) are illustrated in the Table 7. Overall, similar trends to definitions 1 and 2
are observed. Women with a history of RM of three or more consecutive losses were
slightly older, more parous, and more likely to have had infertility treatment
previously. The mean (±SD) age of women with a history of RM was 34.9+5.4 years
compared to 33.8+4.8 years in women without a history of RM. In general, women
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with a history of RM had on average two more children than those without a RM
history (mean ± SD gravidity 7.2 ± 2.4 versus 4.9 ± 2.0, respectively). About a third
(28.2%) of women with RM reported that they had undergone previous infertility
treatment compared to 9.7% of those without a history of RM. Women with a history
of RM also reported a slightly higher amount of employment levels (47.3%) as
compared to those without such a history (37.4%). There were no significant
differences in the planning status of the current pregnancy, education, or consanguinity
between the two groups (p>0.05).

Table 7: Characteristics of pregnant women with gravidity of three or more according
to their history of recurrent miscarriage (RM) status (consecutive or any loss) in Al
Ain Abu Dhabi

Age (years)
Gestational age at
recruitment (months)
Number of pregnancies
Worrying about birth
Yes
No
Social support
Yes
No
Education
High school and
below
Diploma and above
Employment
Employed
Unemployed/Student
Number of people living
in home

Consecutive
p3 losses No losses but value
(n=61,
gravidity >3
3.4%)
(n=1745,
96.6%)
34.9+5.4
33.8+4.8
0.08
0.01
5.5+2.3
6.2+2.3
7.2+2.4
45
(62.5%)
27
(37.5%)

4.9+2.0

<0.001
0.990

3 losses
(n=106,
5.9%)

Any
No losses
(n=1700,
94.1%)

35.5+5.4

33.8+4.8

0.0005

5.8+2.2

6.2+2.3

0.045

7.8+2.4

4.8+1.9

<0.001
0.80

724 (62.6%)

65 (63.7%)

433 (37.4%)

37 (36.3%)

704
(62.5%)
423
(37.5%)

0.51
62
(86.1%)
10
(13.9%)

0.82

1,025
(88.7%)

91 (89.2%)

131 (11.3%)

11 (10.8%)

996
(88.5%)
130
(11.5%)

0.54
49
(66.2%)
25
(33.8%)

0.55

733 (62.7%)

62 (60.2%)

436 (37.3%)

41 (39.8%)

720
(63.2%)
420
(36.8%)

0.090
35
(47.3%)
39
(52.7%)
11.6+8.3

0.49

436 (37.4%)

42 (41.2%) 60 (58.8%)

729 (62.6%)

60 (58.8%)

708
(62.3%)

12.0+8.1

12.1+7.8

12.2+7.7

0.59

pvalue

0.89
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Table 7: Characteristics of pregnant women with gravidity of three or more
according to their history of recurrent miscarriage (RM) status (consecutive or any
loss) in Al Ain Abu Dhabi. (continued)

Previous Gestational
Diabetes Mellitus
Yes
No
Consanguinity
Yes (via parents)
No
Previous infertility
treatment
Yes

Consecutive
p3 losses No losses but value
(n=61,
gravidity >3
3.4%)
(n=1745,
96.6%)
0.99
25
(35.2%)
46
(64.8%)

3 losses
(n=106,
5.9%)

Any
No losses
(n=1700,
94.1%)

0.23

408 (35.2%)

41 (40.6%)

752 (64.8%)

60 (59.4%)

392
(34.7%)
738
(65.3%)

0.98
27
(45.8%)
32
(65.2%)

pvalue

0.74

470 (45.9%)

38 (44.2%)

553 (54.1%)

48 (55.8%)
<0.001

459
(46.1%)
537
(53.9%)
<0.001

20
111 (9.7%)
23 (23.0%) 108 (9.7%)
(28.2%)
No
51
1,033
1,007
77 (77.0%)
(71.8%)
(90.3%)
(90.3%)
Missing data were excluded from the calculation of proportions and means presented for each variable;
mean and standard deviation.

3.3 Behaviors of Women with History of Recurrent Miscarriage Before and
During Index Pregnancies
In this section, the descriptive characteristics of behaviors of women with a history of
RM and their behaviors in the index pregnancy will be summarized.
Table 8 summarizes the distributions of the behaviors of planned pregnancy,
contraceptive non-use, antenatal care initiation and folate use.
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Table 8: Descriptive characteristics of behaviors of pregnant women before and during
index pregnancies according to different definitions of loss
Definition of loss
Two or more losses
Three or more losses
Consecutive
Any
Consecutive
Any
Yes
No
Yes
No
Yes
No
Yes
No
Planned pregnancy
Yes
114
625
117
649
38
522
57
503
(51.8%) (46.5%)
(49.0%) (46.9%)
(52.8%) (45.2%) (56.4%) (44.7%)
No
106
751
122
735
34
633
44
623
(48.2%) (53.5%)
(51.0%) (53.1%)
(47.2%) (54.8%) (43.6%) (55.3%)
P-value
0.14
0.556
0.21
0.023
Contraceptive non-use
No usage 135
667
137
665
49
546
61
534
(60.0%) (46.4%)
(55.2%) (47.0%)
(65.3%) (46.1%) (58.7%) (46.2%)
Any usage 90
771
111
750
26
639
43
622
(40.0%) (53.6 %)
(44.8%) (53.0%)
(34.7%) (53.9%) (41.4%) (53.8%)
P-value
<0.001
0.017
0.001
0.015
Antenatal care initiation
Appropriate 24
108
23
109
9
85
10
84
(60.0%) (36.5%)
(54.8%) (37.1%)
(75.0%) (36.2%) (66.7%) (36.2%)
Late
16
188
19
185
3
150
5
148
(40.0%) (63.5%)
(45.2%) (62.9%)
(25.0%) (63.8%) (33.3%) (63.8%)
P-value
0.004
0.028
0.007
0.019
Folate use
Daily
Not daily
P-value

44
(22.1%)
155
(77.9%)

186
(14.6%)
1,087
(85.4%)
0.007

47
(21.2%)
175
(78.8%)

265
(16.0%)
1395
(84.0%)
0.05

16
142
(24.2%) (13.5%)
50
912
(75.8%) (86.5%)
0.015

22
136
(23.2%) (13.3%)
73
889
(76.8%) (86.7%)
0.008

3.3.1 Planned Pregnancy
There was no significant relationship between a history of loss and planning the
subsequent pregnancy. Women with consecutive losses (2 or 3) and more losses (3 and
more) were slightly more likely to have planned pregnancies with frequencies of
51.8%, 52.8% and 56.4% for two or more consecutive losses, three or more
consecutive losses and three or more any losses respectively. However, none of this
associations reached statistical significance (p value>0.05) (Table 8).
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3.3.2 Contraceptive Use
A history of consecutive loss was associated with the non-use of contraception in the
year preceding the index pregnancy (subsequent pregnancy). Women with a history of
consecutive losses were less likely to use contraceptives in the year preceding their
pregnancy as compared to women without a history of loss. This was true for women
with a history of two (60.0% versus 46.4%, p<0.001) or more consecutive losses and
three or more losses (65.3% versus 46.1%, p =0.001). This trend was also observed
when the losses were both non-consecutively or consecutively two or three and more
(Table 8).
3.3.3 Antenatal Care Initiation
Despite the type of loss, women with any history of loss were more appropriate in their
antenatal care initiation. Women with two or more consecutive losses were more likely
than those without such a history to report for antenatal care initiation appropriately
(60.0% versus 36.5%, p=0.004). Similarly, women with three or more consecutive
losses were more likely than those without a history of three or more losses to report
for antenatal care appropriately (75.0% versus 36.2%, p =0.007) (Table 8).
3.3.4 Folate Use Before Pregnancy
Generally, women with a history of RM were more likely to consume folate daily
before pregnancy as compared to women without a history of RM. With respect to
consecutive losses, it was found that 22.1 % (n=44) women were using folate daily
before pregnancy when they had 2 consecutive losses compared to 14.6% (n=186) of
those who did not have 2 consecutive losses. Similarly, for those with 3 consecutive
losses, 24.2 % (n=16) were using folate daily if they had a history of RM but only

41
13.5% (n=142) of those without history consumed folate daily before their pregnancy
(Table 8).
3.3.5 Physical Activity
There seemed to be no significance between a history of loss and participating in any
amount of physical activity before and during the subsequent pregnancy. Regardless
of whether the women had a history of loss or not, they were less likely to participate
any physical activity before their pregnancy (p>0.05) (Table 9).

Table 9: Description of physical activity before and during pregnancy among pregnant
women according to different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Yes

Three or more losses
Consecutive
Any
No

Yes

No

Yes

No

Physical Activity before pregnancy
Yes
86
542
95
533
(44.6%) (44.2%) (44.8%) (44.2%)
No
107
683
117
673
(55.4%) (55.8%) (55.2%) (55.8%)
P-value
0.935
0.868

27
444
(44.3%) (44.2%)
24
560
(55.7%) (55.8%)
0.995

42
429
(48.3%) (43.9%)
45
549
(51.7%) (56.1%)
0.427

Physical Activity during pregnancy
Yes
66
406
68
404
(52.8%) (49.6%) (50.0%) (50.1%)
No
59
412
68
403
(47.2%) (50.3%) (50.0%) (49.9%)
P-value
0.51
0.989

21
342
(51.2%) (50.4%)
20
336
(48.8%) (49.6%)
0.923

34
329
(59.7%) (49.7%)
23
333
(40.3%) (50.3%)
0.149

Women in general were more likely to participate in any physical activity during the
subsequent pregnancy. Women with a history of loss were also more likely to take part
in physical activity during the pregnancy as compared to the women who did not have
a history of two or more consecutive losses. Although not statistically significant,
women with two or more consecutive losses were more likely to conduct physical
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activity during their index pregnancy as compared to women without such a history
(52.8% versus 49.6%, p=0.510) (Table 9).
3.3.6 Body Mass at First Recorded Visit
The initial body mass of women with a history of any type of RM was always slightly
higher as compared to their comparison groups; however, none of them reached
statistical significance (Table 10).

Table 10: Mean and Standard deviation of weight and blood pressure measured at first
visit during index pregnancy among pregnant women according to different definitions
of loss
Definition of loss
Two or more losses
Three or more losses
Consecutive
Any
Consecutive
Any
Yes
No
Yes
No
Yes
No
Yes
No
Weight at first recorded visit
Mean ±SD (kg)
72.9±
72.1± 73.3±
72.1± 73.3±
73.2± 72.9±
73.2±
14.3
14.7
13.3
14.9
13.8
14.5
14.0
14.5
P-value
0.479
0.249
0.958
0.813
Diastolic blood pressure at first visit
Mean ±SD (mmHg)
67.3±
65.4± 66.8±
65.4± 67.3±
65.7± 67.6±
65.6±
9.8
9.5
10.2
9.4
11.2
9.5
10.7
9.5
P-value
0.007
0.05
0.185
0.05
Systolic blood pressure at first visit
Mean ±SD (mmHg)
93.7±
92.9± 93.4±
92.9± 93.8±
93.1± 93.8±
93.0±
26.6
26.7
27.4
26.5
27.4
26.6
27.1
26.6
P-value
0.676
0.799
0.831
0.796

3.3.7 Blood Pressures at First Visit
Women with a history of loss were more likely to have elevated diastolic blood
pressure profiles during their first visit of their index pregnancy. Women with a history
of 2 consecutive losses had a DBP of 67.3 mmHg (SD± 9.8) as compared to women
without a history of 2 consecutive losses (mean 65.4mmHG (SD± 9.5)) (p=0.007).
This trend seemed to prevail in the exposure groups of any two losses and any three
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losses. However, it did not attain statistical significance when comparing exposure
groups of three or more consecutive losses (Table 10).
Contrary to DBP, systolic blood pressures (SBP) showed no statistical differences
between the various definitions of losses and their comparison groups (p>0.05) as
shown in Table 10 above.
3.3.8 Inter-pregnancy Interval
Women with a history of RM were associated with having a shorter inter-pregnancy
interval. Women with a history of two or more consecutive pregnancy losses had a
mean interval of 29.6 month (SD± 20.7) as compared to women without a history of
RM (35.4 months (SD± 22.1)) (p=0.0018). This trend prevailed in all the definitions
but was only significant for the definitions of two or more consecutive losses and any
three losses (p=0.06) (Table 11).

Table 11: Description of inter-pregnancy interval before index pregnancy among
pregnant women with different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Inter-pregnancy interval
Mean (month)
29.6
35.4
±SD
±20.7
±22.1
P-value
0.0018

Three or more losses
Consecutive
Any

Yes

No

32.4
±24.2

35.1
±21.6
0.13

Yes

No

33.1
36.1
±26.9
±22.3
0.367

Yes

No

30.9
±23.6

36.3
±22.5
0.06

3.3.9 Sedentary Behavior
There was no significant difference between a history of loss and the advent of
sedentary behavior in the subsequent pregnancy. Overall, women were sitting for 6.9
hours (SD± 3.6 hours) during the weekday and 7.9 hours (SD± 4.1 hours) in the whole
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population. There seemed to be no notable differences when comparing them to the
different types of history of loss (Table 12).

Table 12: Description of sedentary behavior during the weekdays and weekends of the
index pregnancy among pregnant women with different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Yes

Three or more losses
Consecutive
Any
No

Sitting hours during weekday during pregnancy
Mean (hours)
7.8 ±
7.7 ±
7.8 ±
7.7 ±
±SD
4.0
4.1
4.2
4.1
P-value
0.825
0.794
Sitting hours during weekend during pregnancy
Mean (hours)
7.0
7.0
6.8
7.0
±SD
±3.3
±3.8
±3.6
±3.8
P-value
0.987
0.469

Yes

No

Yes

No

8.3 ±
4.0

7.7 ±
4.1
0.251

7.9
±4.0

7.7 ±
4.1
0.652

7.0
±3.2

7.0
±3.8
0.931

6.6
±3.3

7.0
±3.8
0.293

Again, there is no significant difference in the number of hours that women were sitting
during the weekend with respect to their history of loss (p>0.05).
3.3.10 Smoking During Pregnancy
The prevalence of smoking was extremely low in this population (n= 21, 0.79%).
Nevertheless, there was no association between smoking and a history of pregnancy
loss. It was interesting, however, to note that none (0.0%) of the women with a history
of loss (two or three, consecutive or not) smoked during the index pregnancy (Table
13).
With respect to smoking before the index pregnancy, there was a slightly higher
prevalence of smoking among the participants (n=38, 1.43%). There were more
women who experienced a history of loss who were smoking before pregnancy as
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compared to none during pregnancy. However, it is still an extremely modest
prevalence of smoking prior to pregnancy regardless of history of loss (Table 13).

Table 13: Description of maternal and paternal smoking behavior before and during
the index pregnancy among pregnant women with different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Yes

Three or more losses
Consecutive
Any
No

Smoking during pregnancy
222
1,426
45
1,403
Never
(100%) (99.2%) (100%) (99.2%)
0
0
11
Ever
11 (0.8%)
(0.0%)
(0.0%)
(0.8%)
P-value
0.191
0.166
Smoking before pregnancy
220
1,423
242
1,401
Never
(99.1%) (98.8%) (99.2%) (98.8%)
2
17
Ever
17 (1.2%) 2(0.8%)
(0.9%)
(1.2%)
P-value
0.715
0.607
Husband smoked before pregnancy
130
840
137
833
Never
(58.6%) (58.6%) (55.7%) (59.1%)
92
594
109
577
Ever
(41.4%) (41.4%) (44.3%) (40.9%)
P-value
0.996
0.32
Husband smokes during pregnancy

Yes

No

Yes

No

72
1,171
(100%)
(99.2%)
0
9
(0.0%)
(0.8%)
0.457

102
1,141
(100%)
(99.2%)
0
9
(0.0%)
(0.8%)
0.37

71
(98.6%)

1,169
(98.9%)
13
1(1.4%)
(1.1%)
0.821

101
(99.0%)

36
708
(49.3%) (60.0%)
37
471
(50.7%) (40.0%)
0.07

54
690
(52.9%) (60.0%)
48
460
(47.1%) (40.0%)
0.164

141
906
151
896
(63.5%) (62.9%) (61.9%) (63.2%)
81
534
93
522
Ever
(36.5%) (37.1%) (38.1%) (36.8%)
P-value
0.864
0.697
Husband quit during pregnancy

40
762
(55.6%) (64.5%)
32
420
(44.4%) (35.5%)
0.126

62
740
(61.4%) (64.2%)
39
413
(38.6%) (35.8%)
0.575

Did not
quit

32
(86.5%)

9 (81.3%)

Never

Quit
P-value

80
517
92
505
(87.0%) (87.5%) (85.2%) (87.8%)
2
6
0
4 (15.5%)
(13.0%)
(14.8%) (12.2%)
0.888
0.448

06
(86.8%)
2
5 (13.5%)
(13.3%)
0.963

1,139
(98.9%)
13
1(1.0%)
(1.1%)
0.891

399
(87.3%)
58
9 (18.8%)
(12.7%)
0.239

3.3.11 Husbands Smoking
Overall, 42.8% among husbands of participants smoked before the index pregnancy.
The prevalence of smoking reduced to 38.4% during the pregnancy. There was no
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statistical difference between smoking during and before pregnancy and the different
definitions of RM (Table 13).
In general, despite the non-significant differences between the RM groups and the non
RM groups, when defined as any losses, there seemed to be a slight increase in
husbands smoking during the pregnancy if the woman had any loss of two (38.1%
versus 36.8%) or three (38.6% versus 35.8%. This slight increase persisted when the
loss was three consecutive losses (44.4% versus 35.5%) while did not follow the same
trajectory when it was two consecutive losses (36.5% versus 37.1%).
A total of 139 men (12.3%) who had smoked before the pregnancy seem to have quit
during the pregnancy. The variations in quitting based on the type of loss are illustrated
in Table 13. In brief, there seemed to be a slight increase in quitting among men
married to women who have had a history of RM for some definitions. These trends
did not reach statistical significance (Table 13).
3.4 Maternal Outcomes in Subsequent Pregnancies of Women with History of
RM
3.4.1 Gestational Diabetes Mellitus
In general, the incidence of GDM among women in the population was 23.2% (n=594)
per pregnancy. There were no differences in the incidence of GDM based on the RM
history of the women. There seemed to be slight increase in GDM in some categories
of definition, but none met statistical significance (Table 14).
3.4.2 Pre-eclampsia
The incidence of pre-eclampsia in the population was 2.1%.. With respect to RM, there
are some differences between women with a history of RM and those without such a
history. The only definition that showed a statistical significance however was the two
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or more consecutive losses. Women with a history of two or more consecutive losses
are more likely to be diagnosed with pre-eclampsia compared to those without a
history of two or more consecutive losses (3.2% versus 1.2%, p= 0.021) (Table 14).
3.4.3 Cesarean Section
The incidence of cesarean section in this population was 23.3% (n=644). Women who
had a history of RM were generally more likely to have a cesarean section as compared
to women without a history of RM. Women with two or more consecutive losses who
had cesarean sections were 34.2% of the population as compared to women who did
not have such a RM history (21.8%) (p<0.001). The trend continued with the definition
of RM in three or more consecutive losses. Women with three or more consecutive
losses who had cesarean sections in their index pregnancy were 43.4% as compared to
23.2% of those without such a history of RM (p<0.001). Even with no consecutive
losses, women with RM were more likely to have cesarean sections (Table 14).
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Table 14: Maternal outcomes in subsequent pregnancies among pregnant women with
different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Gestational diabetes mellitus
51
360
Yes
(24.2%) (26.1%)
160
1,021
No
(75.8%) (73.9%)
P-value
0.557
Pre-eclampsia
7
17
Yes
(3.2%)
(1.2%)
213
1,415
No
(96.8%) (98.8%)
P-value
0.996
Cesarean section
80
327
Yes
(34.2%) (21.8%)
154
1,176
No
(65.8%) (78.2%)
P-value
<0.001

Yes

Three or more losses
Consecutive
Any
No

Yes

No

Yes

No

59
352
(25.7%) (25.8%)
171
1,010
(74.3%) (74.2%)
0.951

18
315
(26.9%) (27.4%)
49
834
(73.1%) (72.6%)
0.922

28
305
(29.8%) (27.2%)
66
817
(70.2%) (72.8%)
0.587

6
18
(2.5%)
(1.3%)
234
1,394
(97.5%) (98.7%)
0.32

2
18
(3.6%)
(1.5%)
68
1,172
(97.1%) (98.5%)
0.07

3
17
(3.0%)
(1.5%)
96
1,144
(97%)
(98.5%)
0.164

83
324
(32.5%) (21.9%)
172
1,158
(67.5%) (78.1%)
<0.001

33
287
(43.4%) (23.2%)
43
953
(56.6%) (76.8%)
<0.001

37
283
(34.9%) (23.4%)
69
927
(65.1%) (76.6%)
0.008

3.4.4 Blood Loss During Labor and Delivery
The average amount of blood loss during labor and delivery was approximately 381ml
(SD± 296). Blood loss ranged from 20 ml to 2500 ml (2.5 liters) of blood in the
population. Generally, with any definition of RM, women with a history of RM were
more likely to lose more blood. Women with two or more consecutive losses lost on
average 446 ml of blood while those without such a history lost 356 ml of blood.
Similarly, women with three or more consecutive losses lost about 488 ml of blood
while women without such a history lost 363 ml of blood (Table 15).
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Table 15: Description of amount of blood loss and length of hospital stay during
delivery as an outcome of the index pregnancy among women with different
definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Blood loss during delivery
Mean (ml)
446.1
355.8
±SD
±306.0
±276
P-value
0.001

Yes

Three or more losses
Consecutive
Any
No

417.9
359.5
±302.4
±278
0.03

Length of hospital stay during delivery
Mean (days)
2.5
2.3
2.5
2.3
±SD
±1.3
±1.4
±1.3
±1.4
P-value
0.05
0.06

Yes

No

Yes

No

487.7
362.6
±329
±284
0.005

451.4
363.7
±332
±283
0.03

2.9
±1.5

2.7
±1.4

2.3
±1.4
0.004

2.3
±1.4
0.02

3.4.5 Length of Hospital Stay During Delivery
Women with a history of any type of RM were in general more likely to stay longer,
albeit a short amount, in the hospitals during their index delivery. For instance, women
with two or more consecutive RMs stayed for 2.5 days (SD± 1.3) while women without
a history of two or more consecutive RMs stayed for 2.3 days (SD± 1.4) (Table 15).
3.5 Neonatal Outcomes of Babies of Women with a History of RM
3.5.1 Birth Weight of Baby
Children born to women with a history of RM were lighter than children of women
without such a history. In general, the differences ranged between 128 grams (any two
losses) to 215 grams (3 consecutive losses) (Table 16).

50
Table 16: Description of birth weight as a fetal outcome of the index pregnancy among
women with different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Birth weight of baby
Mean (grams)
2950.6 3101.3
±SD
±641.2 ±495.1
P-value
<0.001

Yes

Three or more losses
Consecutive
Any
No

2971.9 3099.9
±624.0 ±496.9
<0.001

Yes

No

2875.9 3090.6
±735.5 ±517.1
0.002

Yes

No

2918.9 3092.7
±683.1 ±516.2
0.003

3.5.2 Preterm and Very Preterm Birth
The incidence of preterm birth in this population was 8.7% (n=211) while that of very
preterm births (32 weeks and below) was 1.2% (n=29). Women with a history of RM
were more likely to have preterm births in their subsequent pregnancy (index
pregnancy). The differences in incidence of very preterm births among the different
definitions of RM are shown in Table 17.
3.5.3 NICU Admission
Children born to women with a history of RM were more likely to be admitted to
NICU. While about 17.5% of children born to women with a history of two or more
consecutive RM were admitted to NICU, only 12.0% of those born with no such
history were admitted (p=0.018). This trend continued for all other definitions (Table
17).
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Table 17: Description of preterm and very preterm birth and NICU admission as fetal
outcomes of the index pregnancy among women with different definitions of loss
Definition of loss
Two or more losses
Consecutive
Any
Yes

No

Yes

Three or more losses
Consecutive
Any
No

Yes

No

Yes

No

Preterm babies
32
99
(16.2%)
(7.5%)
166
1,225
No
(83.8%) (92.5%)
P-value
<0.001
Very Preterm babies
9
8
Yes
(4.5%)
(0.6%)
187
1,316
No
(95.4%) (99.4%)
P-value
<0.001
NICU Admission
43
168
Yes
(19.6%) (11.7%)
177
1,264
No
(80.4%) (88.3%)
P-value
0.001
Yes

29
102
(13.2%)
(7.8%)
191
1,200
(86.8%) (92.2%)
0.009

14
93
(22.6%) (8.5%)
48
1,006
(77.4%) (91.5%)
<0.001

15
92
(16.9%)
(8.6%)
74
980
(83.1%) (91.4%)
0.01

9
8
(4.1%)
(0.6%)
209
1,294
(95.9%) (99.4%)
<0.001

5
12
(8.3%) (1.1%)
55
1,087
(91.7%) (98.9%)
<0.001

6
11
(6.8%)
(1.0%)
82
1,060
(93.2%) (99.0%)
<0.001

42
169
(17.5%) (12.0%)
198
1,243
(82.5%) (88.0%)
0.018

17
147
(24.3%) (12.4%)
53
1,043
(75.7%) (84.6%)
0.004

19
145
(19.2%) (12.5%)
80
1,016
(80.8%) (87.5%)
0.06

3.6 Regression Models on Characteristics, Behaviors and Outcomes in
Subsequent Pregnancies Based on Different Definitions of RM

Definition 1: Associate behaviors and pregnancy outcomes of women who have
had two or more consecutive losses

The associations between pregnancy loss defined as two or more consecutive losses
and socio-demographic factors are described in Table 18.
Multivariate regression using all the factors in the table showed that while having a
history of two or more consecutive RM was more associated with lower maternal age
at the index pregnancy (aOR 0.90 95% CI 0.86-0.94), it was also associated with
increased total number of pregnancies prior to the index pregnancy (aOR 1.62, 95%
CI 1.48-1.78) and a history of infertility treatment (aOR: 3.87, 95% CI 2.37-6.33)
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Women to have a history of two or more consecutive RM were also more likely to be
employed (aOR: 1.61, 95% CI 1.08-2.40) when compared to those who did not have
history of two or more consecutive RM.

Table 18: Associations between RM of two or more consecutive pregnancy losses and
socio-demographics factors
Socio-demographics outcomes
Age
Education
Employment
Number of pregnancies
Consanguinity
Social Support
Total number of people living with
participant
Previous infertility treatment

Unadjusted Odds
Ratio (95% CI)
1.04 (1.01-1.07)
1.04 (0.78-1.40)
1.28 (0.96-1.70)
1.43 (1.35-1.52)
0.88 (0.65-1.19)
0.82 (0.53-1.25)
0.99 (0.97-1.01)

Adjusted Odds
Ratio* (95% CI)
0.90 (0.86-0.94)
1.18 (0.78-1.77)
1.61 (1.08-2.40)
1.62 (1.48-1.78)
0.64 (0.44-0.93)
1.08 (0.61-1.91)
0.99 (0.96-1.01)

3.24 (2.23-4.70)

3.87 (2.37-6.33)

*all factors in the table were added into the model

The associations between pregnancy loss with two or more consecutive losses and
behaviors in the subsequent pregnancy are described in Table 19.
Having a history of two or more consecutive RM was independently associated with
having a planned pregnancy (aOR 1.65, 95% CI 1.20-2.27), using no contraception in
the year preceding the index pregnancy (aOR 1.97, 95% CI 1.45-2.70), using folate
before pregnancy (aOR 2.22, 95% CI 1.47-3.34) and coming on time for antenatal care
initiation in the index pregnancy (aOR 0.46, 95% CI 0.22-0.97).
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Table 19: Associations between RM (two or more consecutive losses) and behaviors
in index pregnancy
Variable

Unadjusted Odds Ratio
(95% CI)

Planned Pregnancy

1.24 (0.93-1.65)

Age and parity
adjusted Odds Ratio
(95% CI)
1.65 (1.20-2.27)

No Contraceptive use

1.73 (1.30-2.31)

1.97 (1.45-2.70)

Folate use before pregnancy
Folate use during pregnancy
Physical activity before pregnancy
Physical activity during pregnancy
Smoking before pregnancy
Husbands quitting during pregnancy
Inter-pregnancy interval
Sedentary behavior Weekday
Sedentary behavior Weekend
Late antenatal care initiation

1.66 (1.15-2.40)
1.00 (0.72-1.38)
1.01 (0.75-1.37)
1.14 (0.78-1.65)
0.76 (0.17-3.32)
1.05 (0.55-2.02)
0.78 (0.67-0.91)
1.00 (0.57-1.73)
1.07 (0.58-1.97)
0.38 (0.19-0.75)

2.22 (1.47-3.34)
1.21 (0.85-1.72)
1.10 (0.79-1.54)
1.14 (0.77-1.70)
1.41 (0.30-6.55)
1.13 (0.56-2.28)
0.78 (0.67-0.92)
1.05 (0.57-1.93)
1.03 (0.53-2.03)
0.46 (0.22-0.97)

The associations between pregnancy loss of two or more consecutive losses and
maternal and fetal outcomes in the subsequent pregnancy are described in Table 20. In
the multivariate regression adjusting for common covariates, women with a history of
two or more consecutive RM were associated with increased odds of have a cesarean
section in their index pregnancies (aOR: 1.81, 95% CI 1.24-2.65). They also had more
likelihood of preterm (aOR 2.52, 95% CI 1.56-4.08) and very preterm births (aOR
7.02, 95% CI 2.41-20.46) (Table 20).

54
Table 20: Associations between RM (two or more consecutive losses) and maternal
and fetal outcomes in index pregnancy
Variable
Cesarean section
Preterm birth
Very preterm birth
Blood loss by SD
GDM
Pre-eclampsia
Length of stay during labor
Birth weight
NICU admission

Unadjusted Odds Ratio
(95% CI)
1.87 (1.39-1-2.51)
2.39 (1.55-3.67)
7.92 (3.02-20.77)
1.36 (1.13-1.63)
0.90 (0.65-1.27)
2.74 (1.12-6.67)
1.24 (1.00-1.53)
0.75 (0.65-0.87)
1.08 (1.03-1.13)

Adjusted Odds Ratio*
(95% CI)
1.81 (1.24-2.65)
2.52 (1.56-4.08)
7.02 (2.41-20.46)
1.03 (0.88-1.22)
0.69 (0.47-1.02)
2.81 (0.95-8.27)
1.17 (0.93-1.45)
0.89 (0.78-1.01)
1.04 (0.99-1.10)

*

All models adjusted for age, gravidity, body mass, gestational age at delivery. Preterm birth did not
have gestational age as adjustment due to collinearity. Blood loss was adjusted for cesarean section as
well. SD denotes standard deviation.

Definition 2: Associate behaviors and pregnancy outcomes of women who have
had three or more consecutive losses

The associations between socio-demographic factors and pregnancy loss with three or
more consecutive losses are described in Table 21. Multivariate regression using all
the factors in Table 21 showed that having a history of three or more consecutive RM
was associated with the total number of pregnancies prior to the index pregnancy (aOR
1.51, 95% CI 1.32-1.78) and a history of infertility treatment (aOR: 5.10, 95%CI 2.5110.38). Women who have a history of three or more consecutive RM were also more
likely to be employed (aOR: 2.09, 95% CI 1.07-4.07).
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Table 21: Associations between socio-demographics factors and RM of three or more
consecutive pregnancy losses
Variable

Unadjusted Odds Ratio
(95% CI)
Age
1.05 (0.99-1.10)
Education
0.86 (0.52-1.41)
Employment
1.50 (0.94-2.40)
Number of pregnancies
1.44 (1.32-1.57)
Consanguinity
0.99 (0.59-1.68)
Social Support
0.79 (0.40-1.58)
Total number of people living with 0.99 (0.96-1.02)
participant
Previous infertility treatment
3.65 (2.10-6.34)

Adjusted Odds Ratio*
(95% CI)
0.93 (0.87-1.00)
0.82 (0.41-1.63)
2.09 (1.07-4.07)
1.51 (1.32-1.78)
0.71 (0.38-1.34)
1.02 (0.41-2.52)
1.00 (0.95-1.04)
5.10 (2.51-10.38)

*all factors in the table were added into the model

The associations between pregnancy loss with three or more consecutive losses and
behaviors in the subsequent pregnancy are described in Table 22.
In the multivariate regression associating behaviors in the index pregnancy and having
a history of three or more RM, having a history of three or more consecutive RM was
more independently associated with having a planned pregnancy (aOR 1.73, 95% CI
1.03-2.90), using no contraception in the year preceding the index pregnancy (aOR
2.20, 95% CI 1.32-3.68) and using folate before pregnancy (aOR 2.33, 95% CI 1.224.45) as shown in Table 22.
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Table 22: Associations between RM (three or more consecutive losses) and behaviors
in index pregnancy
Variable
Planned Pregnancy
No Contraceptive use
Folate use before pregnancy
Folate use during pregnancy
Physical activity before pregnancy
Physical activity during pregnancy
Smoking before pregnancy
Husbands quitting during pregnancy
Inter-pregnancy interval
Sedentary behavior Weekday
Sedentary behavior Weekend
Late antenatal care initiation

Unadjusted Odds
Ratio (95% CI)
1.36 (0.84-2.18)
2.21 (1.35-3.60)
2.06 (1.14-3.71)
0.87 (0.50-1.52)
1.00 (0.60-1.69)
1.03 (0.55-1.94)
1.27 (0.16-9.82)
1.02 (0.38-2.73)
0.88 (0.66-1.16)
1.04 (0.42-2.61)
1.81 (0.66-4.97)
0.19 (0.05-0.72)

Age and parity adjusted
Odds Ratio (95% CI)
1.73 (1.03-2.90)
2.20 (1.32-3.68)
2.33 (1.22-4.45)
1.00 (0.55-1.81)
1.06 (0.60-1.85)
0.98 (0.50-1.90)
4.02 (0.45-35.84)
1.22 (0.44-3.39)
0.95 (0.72-1.26)
1.25 (0.46-3.36)
2.02 (0.68-5.98)
0.30 (0.07-1.26)

The associations between pregnancy loss with three or more consecutive losses and
outcomes in the subsequent pregnancy are described in Table 23. In the multivariate
regression adjusting for common covariates, women with a history of three or more
consecutive RM were more associated with a cesarean section in their index
pregnancies (aOR: 2.65, 95% CI 1.41-4.97). They also had more likelihood of preterm
(aOR 3.51, 95% CI 1.76-7.03) and very preterm births (aOR 8.53, 95% CI 2.5029.09).Furthermore, women with such a history also stayed longer in the hospital
during their labor and delivery for the index pregnancy (aOR 1.65, 95% CI 1.10-2.47)
as shown above in Table 23.
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Table 23: Associations between RM (three or more consecutive losses) and maternal
and fetal outcomes in index pregnancy
Variable
Cesarean section
Preterm birth
Very preterm birth
Blood loss by SD
GDM
Pre-eclampsia
Length of stay during labor
Birth weight
NICU admission

Unadjusted Odds
Ratio (95% CI)
2.54 (1.59 -4.09)
3.16 (1.68-5.94)
8.23 (2.80-24.20)
1.53 (1.14-2.04)
0.97 (0.56-1.70)
1.92 (0.44-8.42)
1.78 (1.21-2.63)
0.67 (0.51-0.86)
1.13 (1.04-1.22)

Adjusted Odds Ratio*
(95% CI)
2.65 (1.41-4.97)
3.51 (1.76-7.03)
8.53 (2.50-29.09)
0.99 (0.77-1.30)
0.25 (0.45-1.61)
2.59 (0.51-13.23)
1.65 (1.10-2.47)
0.84 (0.67-1.05)
1.41 (0.65-3.07)

*

All models adjusted for age, gravidity, body mass, gestational age at delivery. Preterm birth did not
have gestational age as adjustment due to collinearity. Blood loss was adjusted for cesarean section as
well. SD denotes standard deviation.

Definition 3: Associate behaviors and pregnancy outcomes of women who have
had two or more losses

The associations between socio-demographic factors and pregnancy loss with 2 or
more losses are described in Table 24.

Table 24: Associations between socio-demographics factors and RM of two or more
pregnancy losses
Variable

Unadjusted Odds
Ratio (95% CI)
Age
1.12 (1.09-1.15)
Education
0.84 (0.63-1.12)
Employment
1.06 (0.81-1.41)
Number of pregnancies
1.84 (1.71-1.98)
Consanguinity
0.93 (0.69-1.25)
Social Support
0.80 (0.53-1.21)
Number of people living with participant 0.99 (0.98-1.01)
Previous infertility treatment
3.00 (2.08-4.34)

Adjusted Odds Ratio*
(95% CI)
0.96 (0.92-1.00)
1.04 (0.68-1.61)
1.46 (0.95-2.24)
1.98 (1.77-2.21)
0.71 (0.48-1.05)
1.12 (0.62-2.04)
0.99 (0.96-1.02)
4.35 (2.58-7.34)

*all factors in the table were added into the model

For any two losses during the pregnancy, only previous gravidity and infertility
treatment were independently significant. Women with such a history of any two
losses had more pregnancies prior to the index pregnancy (aOR 1.98, 95% CI 1.77-
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2.21) and were more than four times likely to have had infertility treatment (aOR 4.35,
95% CI 2.58-7.34).
The associations between pregnancy loss with two or more losses and behaviors in the
subsequent pregnancy are described in Table 25. Women with any history of two or
more losses were more likely to have planned pregnancies (aOR 1.67, 95% CI 1.202.34), use no contraception (aOR 1.73, 95% CI 1.25-2.39), consume folate before the
index pregnancy (aOR 2.60, 95% CI 1.67-4.06) and have shorter inter-pregnancy
intervals (IPIs) (aOR 0.80, 95% CI 0.68-0.95) between their previous pregnancy and
their index pregnancy.

Table 25: Associations between RM (two or more losses) and behaviors in index
pregnancy
Variable
Planned Pregnancy
No Contraceptive use
Folate use before pregnancy
Folate use during pregnancy
Physical activity before pregnancy
Physical activity during pregnancy
Smoking before pregnancy
Husbands quitting during pregnancy
Inter-pregnancy interval
Sedentary behavior Weekday
Sedentary behavior Weekend
Late antenatal care initiation

Unadjusted Odds
Ratio (95% CI)
1.09 (0.83-1.43)
1.39 (1.06-1.83)
1.57 (1.09-2.24)
0.79 (0.57-1.09)
1.03 (0.76-1.38)
0.99 (0.69-1.43)
0.68 (0.16-2.97)
1.25 (0.70-2.26)
0.89 (0.77-1.03)
0.82 (0.49-1.39)
1.08 (0.60-1.94)
0.49 (0.25-0.93)

Age and parity adjusted
Odds Ratio (95% CI)
1.67 (1.20-2.34)
1.73 (1.25-2.39)
2.60 (1.67-4.06
0.97 (0.67-1.41)
1.05 (0.74-1.50)
0.97 (0.63-1.49)
1.83 (0.33-10.00)
1.27 (0.62-2.57)
0.80 (0.68-0.95)
0.78 (0.41-1.48)
1.08 (0.54-2.19)
0.57(0.27-1.21)

The associations between pregnancy loss with two or more losses and outcomes in the
subsequent pregnancy are described in Table 26.
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Table 26: Associations between RM (two or more losses) and maternal and fetal
outcomes in index pregnancy
Variable
Cesarean section
Preterm birth
Very preterm birth
Blood loss by SD
GDM
Pre-eclampsia
Length of stay during labor
Birth weight
NICU admission

Unadjusted Odds
Ratio (95% CI)
1.72 (1.29-2.30)
1.79 (1.15-2.77)
6.97 (2.66-18.26)
1.22 (1.02-1.46)
0.99 (0.72-1.36)
1.99 (0.78-5.05)
1.21 (0.99-1.48)
0.78 (0.68-0.90)
1.06 (1.01-1.11)

Adjusted Odds Ratio*
(95% CI)
1.74 (1.17-2.58)
1.72 (1.01-2.93)
6.31 (1.92-20.75)
0.98 (0.83-1.17)
0.63 (0.43-0.94)
2.03 (0.57-7.21)
1.16 (0.92-1.45)
0.85 (0.75-0.97)
1.14 (0.68-1.91)

*

All models adjusted for age, gravidity, body mass, gestational age at delivery. Preterm birth did not
have gestational age as adjustment due to collinearity. Blood loss was adjusted for cesarean section as
well. SD denotes standard deviation.

Women with a history of any two losses prior to the index pregnancy were more likely
to have cesarean section (aOR 1.74, 95% CI 1.17 -2.58), preterm (aOR 1.72, 95% CI
1.01-2.93) and very preterm birth (aOR 6.31, 95% CI 1.92 -20.75) in their index
pregnancy. Contrarily, a history of any two losses was more likely to be associated
with less incidence of GDM in their index pregnancy (aOR 0.63, 95% CI 0.43-0.94)
and a lower birth weight baby (aOR 0.85, 95% CI 0.75-0.97). This was significant
even after adjusting for age, gravidity, weight at first visit and gestational age at
delivery as shown in Table 26.

Definition 4: Associate behaviors and pregnancy outcomes of women who have
had three or more non-consecutive losses

The associations between socio-demographic factors and pregnancy loss with 3 or
non-more consecutive losses are described in Table 27. Lastly, looking at the
independent associations of socio-demographic characteristics, the associations
between any three losses in their reproductive career and both the total number of
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pregnancies (aOR 1.74, 95% CI 1.53-1.98) and previous infertility treatment (aOR
3.44, 95% CI 1.72-6.89) were significant.
Table 27: Associations between socio-demographics factors and RM of three or more
pregnancy losses
Variable
Age
Education
Employment
Number of pregnancies
Consanguinity
Social Support
Number of people living with participant
Previous infertility treatment

Unadjusted Odds
Ratio (95% CI)
1.08 (1.03-1.13)
1.13 (0.75-1.71)
1.16 (0.77-1.74)
1.67 (1.53-1.83)
0.93 (0.59-1.44)
1.08 (0.56-2.07)
1.00 (0.97-1.03)
2.79 (1.68-4.62)

Adjusted Odds
Ratio* (95% CI)
0.95 (0.89-1.02)
1.40 (0.76-2.58)
1.35 (0.74-2.48)
1.74 (1.53-1.98)
0.62 (0.35-1.08)
1.43 (0.59-3.44)
0.99 (0.96-1.03)
3.44 (1.72-6.89)

*all factors in the table were added into the model

The associations between pregnancy loss with three or more losses and behaviors in
the subsequent pregnancy are described in Table 28. Women with history of any three
losses were more likely to plan their index pregnancy (aOR 2.48, 95% CI 1.54-4.00),
use no contraception (aOR 1.73, 95% CI 1.10-2.71) and use folate before their index
pregnancy (aOR 2.55, 95% CI 1.41-4.63).

Table 28: Associations between RM (three or more losses) and behaviors in index
pregnancy
Variable
Planned Pregnancy
No Contraceptive use
Folate use before pregnancy
Folate use during pregnancy
Physical activity before pregnancy
Physical activity during pregnancy
Smoking before pregnancy
Husbands quitting during pregnancy
Inter-pregnancy interval
Sedentary behavior Weekday
Sedentary behavior Weekend
Late antenatal care initiation

Unadjusted Odds
Ratio (95% CI)
1.60 (1.06-2.42)
1.65 (1.10-2.48)
1.97 (1.18-3.28)
0.87 (0.55-1.40)
1.19 (0.77-1.85)
1.50 (0.86-2.60)
0.87 (0.11-6.70)
1.59 (0.73-3.45)
0.79 (0.62-1.01)
0.65 (0.30-1.44)
1.22 (0.51-2.91)
0.28 (0.09-0.86)

Age and parity adjusted
Odds Ratio (95% CI)
2.48 (1.54-4.00)
1.73 (1.10-2.71)
2.55 (1.41-4.63)
1.06 (0.63-1.80)
1.17 (0.72-1.91)
1.53 (0.85-2.78)
4.47 (0.43-46.40)
1.78 (0.73-4.37)
0.82 (0.64-1.05)
0.61 (0.25-1.51)
1.25 (0.47-3.35)
0.44 (0.13-1.48)
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The associations between pregnancy loss with three or more losses and outcomes in
the subsequent pregnancy are described in Table 29. Women with a history of any
three losses were more likely to be independently associated with preterm (aOR: 2.28,
95% CI 1.15 -4.52) and very preterm births (aOR 8.63, 95% CI 2.40-31.01) in their
index pregnancy as compared to women who did not have a history of three losses but
have a gravidity of three or more as shown in Table 29.

Table 29: Associations between RM (three or more) and maternal and fetal outcomes
in index pregnancy
Variable
Cesarean section
Preterm birth
Very preterm birth
Blood loss by SD
GDM
Pre-eclampsia
Length of stay during labor
Birth weight/SD
NICU admission

Unadjusted Odds Ratio
(95% CI)
1.76 (1.15-2.68)
2.16 (1.19-3.91)
7.05 (2.54-19.55)
1.34 (1.03-1.75)
1.14 (0.72-1.80)
2.10 (0.61-7.30)
1.46 (1.05-2.01)
0.72 (0.58-0.90)
1.07 (0.99-1.15)

Adjusted Odds Ratio*
(95% CI)
1.59 (0.91-2.81)
2.28 (1.15-4.52)
8.63 (2.40-31.01)
1.02 (0.80-1.31)
0.96 (0.56-1.63)
1.83 (0.34-9.81)
1.38 (0.97-1.95)
0.83 (0.69-1.01)
1.11 (0.54-2.27)

*

All models adjusted for age, gravidity, body mass, gestational age at delivery. Preterm birth did not
have gestational age as adjustment due to collinearity. Blood loss was adjusted for cesarean section as
well. SD denotes standard deviation.

3.7 Differences in Outcomes Based on Chronology
3.7.1 Immediate RM
Using 2 consecutive losses as the standard for RM, the timing of the RM was
investigated to see if it made any differences in the outcomes or behaviors in the
subsequent pregnancy. The comparison was done with other women with a history of
RM but not immediately before the index pregnancy. Out of all women who had RM
(n=234), the total amount of women who experienced RM prior to the index pregnancy
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were 88 (37.6%). The differences in characteristics between women with a history of
RM but with a status of whether it was immediately before the index pregnancy is
depicted in the Table 30.
Women with immediate history of RM were more likely to have less previous
pregnancies (5.32±2.6 versus 6.7±2.5). Furthermore, women who experienced RM
prior to this index pregnancy were more likely to report a planned pregnancy (70.4%
versus 41.0%). Women who did not experience RM immediately before the index
pregnancy were more likely to report lower levels of social support. 16.5% of women
who had a history of RM but not immediately before the index pregnancy reported
lack of social support while only 7.1% of women who had experienced RM
immediately before the index pregnancy reported low levels of social support.

Table 30: Baseline characteristics of women with RM but by status of whether RM
occurred immediately before the index pregnancy or not

N (%)
Age (years)
Gestational age at recruitment (months)
Number of pregnancies
Planned pregnancy
Yes
No
Worrying about birth
Yes
No
Social support
Yes
No
Education
High school and below
Diploma and above
Employment
Employed
Unemployed/Student
Number of people living in home
Previous Gestational Diabetes Mellitus
Yes
No

RM immediately
before index
pregnancy
88 (37.6%)
32.8+6.4
5.75+2.2
5.32+2.6

History of RM but not
immediately before index
pregnancy
146 (62.4%)
34.2+5.0
5.83+2.4
6.7+2.5

57 (70.4%)
24 (29.6%)

57 (41.0%)
82 (59.0%)

56 (66.7%)
28 (33.3%)

96 (69.1%)
43 (30.9%)

78 (92.9%)
6 (7.1%)

116 (83.5%)
23 (16.5%)

50 (60.2%)
33 (39.8%)

87 (62.6%)
52 (37.4%)

33 (39.8%)
50 (60.2%)
10.5+7.0

63 (45.0%)
77 (55.0 %)
12.0+8.0

26 (31.7%)
56 (68.3%)

52 (38.0%)
85 (62.0%)

P - value

0.0583
0.786
0.0001
<0.001
0.710
0.043
0.728
0.445
0.173
0.350
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Table 31: Baseline characteristics of women with RM but by status of whether RM
occurred immediately before the index pregnancy or not (Continued)
Consanguinity
Yes (via parents)
No
Previous infertility treatment
Yes
No

0.173
38 (50.0%)
38 (50.0%)

46 (40.0%)
69 (60.0%)

18 (22.8%)
61(77.2%)

30 (21.7%)
108 (78.3%)

0.858

Other differences such as some of the outcomes and their differences in prevalence
according to immediate RM status are illustrated in Figure 4. It is apparent that
women with a history of immediate RM were more likely to experience GDM in the
index pregnancy (25.9% versus 23.1%).
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Type of adverse outcomes
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3.6
2.4
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Figure 4: Frequencies of maternal and fetal outcomes by status of RM and whether it
was immediately prior to index pregnancy or not amongst pregnant women in the
UAE
The associations between history of immediate RM and socio-demographic factors are
described in Table 31. Overall, there seemed to be no significant differences between
the characteristics of women who have experienced RM immediately before the index
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pregnancy as compared to women who have experienced RM at other times both in
the crude and adjusted model.

Table 32: Associations between socio-demographics factors and RM of two or more
consecutive pregnancy losses and whether status of RM was prior to index pregnancy
Variable
Age
Education
Employment
Number of pregnancies
Consanguinity
Social Support
Number of people living with participant
Previous infertility treatment

Unadjusted Odds
Ratio (95% CI)
0.95 (0.91-1.00)
1.10 (0.63-1.93)
0.81 (0.46-1.40)
0.80 (0.71-0.90)
1.50 (0.84-2.69)
2.58 (1.00-6.62)
0.97 (0.94-1.01)
1.06 (0.55-2.06)

Adjusted Odds
Ratio* (95% CI)
1.02 (0.95-1.10)
1.23 (0.59-2.57)
0.68 (0.32-1.45)
0.77 (0.64-0.91)
1.21 (0.61-2.41)
2.12 (0.68-6.49)
0.96 (0.92-1.01)
0.73 (0.31-1.72)

*all factors in the table were added into the model

With respect to behaviors in the index pregnancy, however, it can be seen that women
who experienced RM immediately before the index pregnancy were independently
associated with a planned pregnancy (aOR: 3.51, 95% CI 1.89-6.55) and folate use
before the index pregnancy (aOR: 2.63, 95% CI 1.27-5.44) as compared to women
who s RM was not before the index pregnancy. The associations between pregnancy
loss with history of immediate prior RM and behaviors in the subsequent pregnancy
are described in Table 32.
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Table 33: Associations between RM of two or more consecutive pregnancy losses and
whether status of RM was prior to index pregnancy and behaviors during the index
pregnancy
Variable

Unadjusted Odds
Ratio (95% CI)

Planned Pregnancy
No Contraceptive use
Folate use before pregnancy
Folate use during pregnancy
Physical activity before pregnancy
Physical activity during pregnancy
Husbands quitting during pregnancy
Inter-pregnancy interval
Sedentary behavior Weekday
Sedentary behavior Weekend
Late antenatal care initiation

3.42 (1.90-6.13)
1.39 (0.80-2.42)
2.89 (1.45-5.76)
0.81 (0.44-1.50)
1.69 (0.94-3.06)
1.12 (0.56-2.28)
2.08 (0.61-7.07)
0.69 (0.51-0.92)
2.01 (0.78-5.20)
2.66 (0.85-8.35)
2.27 (0.50-10.25)

Age and parity
adjusted Odds Ratio
(95% CI)
3.51 (1.89-6.55)
1.21 (0.68-2.15)
2.63 (1.27-5.44)
0.69 (0.36-1.32)
1.48 (0.79-2.76)
1.17 (0.56-2.44)
1.88 (0.53-6.65)
0.69 (0.62-0.92)
1.55 (0.56-4.27)
2.49 (0.75-8.27)
1.54 (0.27-8.68)

The occurrence of RM immediately before the index pregnancy did not seem to have
any association with outcomes in the index pregnancy when compared to RM at other
times. The associations between a history of prior immediate RM and outcomes in the
subsequent pregnancy are described in Table 33.

Table 34: Associations between history of RM of two or more consecutive pregnancy
losses and whether status of RM was prior to index pregnancy and maternal and fetal
outcomes in the index pregnancy
Variable
Cesarean section
Preterm birth
Very preterm birth
Blood loss by SD
GDM
Pre-eclampsia
Length of stay during labor
Birth weight/SD
NICU admission
*

Unadjusted Odds Ratio
(95% CI)
0.78 (0.44-1.37)
1.01 (0.47-2.18)
1.19 (0.31-4.59)
0.68 (0.46-1.00)
1.17 (0.61-2.22)
0.67 (0.13-3.51)
0.92 (0.62-1.35)
0.99 (0.70-1.40)
1.02 (0.91-1.14)

Adjusted Odds Ratio*
(95% CI)
0.66 (0.33-1.32)
0.92 (0.41-2.07)
1.23 (0.31-4.92)
0.74 (0.52-1.06)
1.43 (0.70-2.89)
0.57 (0.089-3.66)
0.96 (0.65-1.42)
0.91 (0.73-1.12)
1.85 (0.76-4.51)

All models adjusted for age, gravidity, body mass, gestational age at delivery. Preterm birth did not
have gestational age as adjustment due to collinearity. Blood loss was adjusted for cesarean section as
well. SD denotes standard deviation.
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3.7.2 RM at Beginning of Reproductive Career
Similar associations were found between women who had primary RM (i.e. had a
history of RM at the beginning of their reproductive career) as compared to women
who have had live births before their onset of RM. Women with primary RM were
more likely to be younger (31.9±5.7 versus 34.9±5.2), have less pregnancies (4.9±2.4
versus 7.1±2.3), employed (51.6% versus 36.7%) and report having previous infertility
treatment (30.5% versus 15.6%). The differences in the characteristics of these women
are described in Table 34.
Table 35: Demographic characteristics of women with primary RM and women with
non-primary RM
N (%)
Age (years)
Gestational age at recruitment (months)
Number of pregnancies
Planned pregnancy
Yes
No
Worrying about birth
Yes
No
Social support
Yes
No
Education
High school and below
Diploma and above
Employment
Employed
Unemployed/Student
Number of people living in home
Previous Gestational Diabetes Mellitus
Yes
No
Consanguinity
Yes (via parents)
No
Previous infertility treatment
Yes
No

Primary RM
100 (42.7)
31.9+5.7
5.8+2.3
4.9+2.4

Not primary RM
134 (57.3)
34.9+5.2
5.8+2.3
7.1+2.3

45 (46.9%)
51 (53.1%)

69 (55.6%)
55 (44.4%)

70 (72.9%)
26 (27.1%)

82 (64.6%)
45 (35.4%)

85 (88.5%)
11 (11.5%)

109 (85.8%)
18 (14.2%))

58 (60.4%)
38 (39.6%)

79 (62.7%)
47 (37.3%)

49 (51.6%)
46 (48.4%)
11.0+7.4

47 (36.7%)
81 (63.3%)
11.9+7.9

28 (30.4%)
64 (69.6%)

50 (39.4%)
77 (60.6%)

28 (35.9%)
50 (64.1%)

56 (49.6%)
57 (50.4%)

29 (30.5%)
66 (69.5%)

19 (15.6%)
103 (84.4%)

P - value
0.0001
0.884
<0.001
0.197
0.185
0.551
0.729
0.027
0.400
0.173
0.062
0.008

Women who had a history of primary RM were also more likely to have had a cesarean
section (44.0% versus 26.9%) as compared to women with RM at other times in their
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reproductive career. The rates of outcomes between the two groups are illustrated in
the Figure 5.
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Figure 5: Frequencies of maternal and fetal outcomes in women with RM versus
those with non-primary RM. *Cesarean section was the only outcome that was
significantly different between the groups

In regression models between primary RM and characteristics of the participants, only
consanguinity and previous infertility treatment had independent associations to
primary RM. Women with primary RM were 55% (aOR 0.45, 95% CI 0.21-0.98) less
likely to be in consanguineous marriages. Women with primary RM were 2.5 times
more likely to have had previous infertility treatment as compared to women with a
history of RM but no primary RM. The associations between socio-demographic
factors and pregnancy loss which were primary RM for women with two or more
consecutive losses are described in Table 35.
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Table 36: Associations between socio-demographics factors and primary RM of two
or more consecutive pregnancy losses
Variable

Unadjusted Odds
Ratio (95% CI)
Age
0.90 (0.86-0.95)
Education
1.10 (0.64-1.90)
Employment
1.84 (1.07-3.15)
Number of pregnancies
0.66 (0.58-0.76)
Consanguinity
0.57 (0.32-1.03)
Social Support
1.28 (0.57-2.85)
Total number of people living with participant 0.98 (0.95-1.02)
Previous infertility treatment
2.38 (1.24-4.59)

Adjusted Odds
Ratio* (95% CI)
0.95 (0.87-1.03)
1.07 (0.48-2.38)
1.56 (0.70-3.48)
0.67 (0.55-0.83)
0.45 (0.21-0.98)
0.90 (0.30-2.73)
1.02 (0.98-1.06)
2.50 (1.02-6.12)

*all factors in the table were added into the model

The behaviors during the index pregnancy did not differ between participants with
primary RM and those with RM at other times of their reproductive career. The
associations between primary RM and behaviors in the subsequent pregnancy are
described below in Table 36.

Table 37: Associations between primary RM of two or more consecutive pregnancy
losses and behaviors during the index pregnancy
Variable

Unadjusted Odds
Ratio (95% CI)

Planned Pregnancy
No Contraceptive use
Folate use before pregnancy
Folate use during pregnancy
Physical activity before pregnancy
Physical activity during pregnancy
Husbands quitting during pregnancy
Inter-pregnancy interval
Sedentary behavior Weekday
Sedentary behavior Weekend
Late antenatal care initiation

0.70 (0.42-1.20)
1.86 (1.07-3.33)
1.23 (0.63-2.41)
1.25 (0.68-2.29)
0.81 (0.46-1.44)
0.63 (0.31-1.27)
0.37 (0.09-1.46)
1.08 (0.81-1.42)
0.85 (0.33-2.14)
1.30 (0.42-4.00)
1.56 (0.42-5.72)

Age and parity
adjusted Odds Ratio
(95% CI)
0.55 (0.29-1.03)
1.57 (0.85-2.92)
0.93 (0.43-2.03)
1.10 (0.55-2.20)
0.67 (0.35-1.29)
0.50 (0.22-1.15)
0.30 (0.07-1.35)
1.26 (0.94-1.70)
0.61 (0.21-1.77)
1.47 (0.41-5.21)
0.94 (0.16-5.45)

However, it was noted that women with a history of RM were 2.28 times (aOR: 2.28,
95% CI 1.09-4.75) more likely to have a cesarean section in their index pregnancy as
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compared to women without primary RM. Other outcomes of interest and their
associations with primary RM can be found in Table 37.

Table 38: Associations between primary RM of two or more consecutive pregnancy
losses and maternal and fetal outcomes in index pregnancy
Variable
Cesarean section
Preterm birth
Very preterm birth
Blood loss by SD
GDM
Pre-eclampsia
Length of stay during labor
Birth weight/SD
NICU admission
*

Unadjusted Odds Ratio
(95% CI)
2.14 (1.23-3.70)
0.99 (0.46-2.12)
0.61 (0.15-2.53)
0.94 (0.65-1.38)
1.06 (0.56-1.99)
1.75 (0.38-8.03)
1.04 (0.71-1.52)
0.88 (0.63-1.24)
0.97 (0.87-1.08)

Adjusted Odds Ratio*
(95% CI)
2.28 (1.09-4.75)
0.83 (0.35-2.00)
0.70 (0.15-3.23)
0.91 (0.65-1.28)
1.21 (0.57-2.57)
2.20 (0.32-15.27)
0.98 (0.65-1.48)
0.97 (0.77-1.22)
0.49 (0.18-1.32)

All models adjusted for age, gravidity, body mass, gestational age at delivery. Preterm birth did not
have gestational age as adjustment due to collinearity. Blood loss was adjusted for cesarean section as
well. SD denotes standard deviation.
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Chapter 4: Discussion

Pregnancy loss, regardless of its definition and quantity, is an issue for the woman who
goes through it, her future pregnancies and for the clinician. On the personal front for
women and their families, it defines psychological distress, physical pain and a
dilemma with respect to future pregnancies and child rearing. It brings about queries
on health and its effects on future children. A reoccurring event of repeated miscarriage
elevates this pain and grief further when two, three or more pregnancies end in a loss.
Women with previous RM have been shown to have anxiety, perceived stress,
depression and limited resting behaviors [89-92]. And when women with a history of
RM have future pregnancies, it opens the prospects of effects on future pregnancies as
well. The current work aimed to study these effects and understand the impact of a
history of RM on women in the UAE.
Recurrent miscarriage is an important public health and clinical issue in the UAE.
Using the definition of a history of RM of two or more consecutive losses, about one
in eight women had a history of RM (13.5%) in this population of pregnant women.
Currently, there is a lack of data on RM in the United Arab Emirates (UAE) and Gulf
Cooperation Council (GCC) countries with only some studies focusing on this topic.
A qualitative study conducted in 2017 evaluated the perception and experience of RM
amongst Arab women (N=12) in the UAE [76] and found that there is a need for
support and affirmation. A cross-sectional study at one hospital in Qatar found that
there was no relationship between consanguinity and RM in Qatari women (N=184)
[93]. While RM is studied more extensively in Saudi, it is usually to show biomarkers
[78], polymorphisms [77] and the effect of abnormalities in RM [79]. Therefore,
assessment of the burden of RM and its influence on maternal health in the region is
lacking. This dissertation has envisioned to provide these estimates as part of the

71
Mutaba ah stud . The effect of RM on the participant s behaviors and future
pregnancy outcomes will be discussed below.
4.1 RM Effects on Pa ien

F

e Beha i

Although the rate of RM in this population is relatively high, it is the effects of RM on
future pregnancies that were most pertinent to this dissertation and for future
directions. This study shows that RM has effects on the behaviors of women in their
future pregnancy. Overall, women with history of RM were more likely to substantiate
their chances of healthy pregnancy by planning, taking folate prior to getting pregnant,
and early initiation of their antenatal care visits in this study. Many previous studies
have linked preconception good behaviors to be associated with pregnancy intention
[94]. It can be assumed that women with history of RM might be more intending to
conceive and, hence showing this association. This is especially true as it is seen that
women with a history of RM had reported higher levels of planned pregnancies in this
population. Although, it was not possible to elucidate whether the women meant
planning to be intention or wanted-ness in this population, pregnancy intention is
usually high in women with previous high risk pregnancies [95].
Multiple studies around the world have shown that women were having shorter interpregnancy intervals (IPIs) when previously having suffered from RM although this did
not translate to an independent association [96]. Most studies are at the consensus that
delaying pregnancies when having suffered a loss does not cause more adverse
outcomes [97-99]. The WHO has advised, that for appropriate physical and mental
healing, a six month break is given for those suffering from previous loss [100]. While
women in this stud s population with a history of RM were having shorter IPIs, they
were still meeting this spacing guideline (mean of about 30 months). However, it is
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noteworthy that women should be educated on the appropriate spacing at events such
as the Weqaya screening or pre-marital screening which are compulsory in the UAE.
Furthermore, women with a history of RM were more likely to not use any type of
contraception in the year preceding the pregnancy. This factor can be linked to the
intention of pregnancy as previously discussed. A study on women with polycystic
ovarian syndrome (PCOS) discussed this concept further [101]. Women with PCOS
are more likely to suffer from RM or sporadic losses. Hence, the comparisons made
can be extrapolated to this population. It was shown that women reporting PCOS were
less likely to be using contraception in their bid to try to conceive and had higher
fertility concerns [101]. Furthermore, if the women were to be having infertility issues
(which was reported to be so in this population), it is suggested that they might be
concerned about contraception as they consider their chances of a pregnancy to be low
anyway [102].
Pre-pregnancy weight and body mass is a common indicator for future outcomes of
the mother and the child. A healthy conception weight can reduce the chances of
miscarriages as well [103]. Contrary to literature [104], women in this population with
a history of RM were not significantly heavier than women without such a history.
Women with a history of RM were about 73 kilograms (Kg) at their first visits while
those without were about 72 Kg. However, it should be noted that majority of the
women in the study were either overweight or obese at the beginning of their
pregnancy.
Women with a history of RM were more likely to initiate early for their antenatal care
booking visits. This is to mean that they were coming at or before 3 months of gestation
during the pregnancy. Women with previous miscarriages have been found to have
better health-seeking behaviors in many other populations [105]. The study
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participants also seem to be on time for their ANC visits if they have experienced
previous miscarriages. Early ANC initiation is important for health providers as it
allows for better monitoring of the fetus at an earlier stage as well as providing
appropriate assistance for women with recurrent miscarriages [105].
Although, women in this population were more likely to substantiate their chances of
pregnancy by taking folate daily before their current pregnancy, this trajectory does
not continue during subsequent pregnancy in women with history of RM. The lack of
association to folate consumption behavior during pregnancy is an interesting concept.
Firstly, this phenomenon can be linked to goal orientation in pregnancy. A very
thought-provoking article on Arab women and their health beliefs discusses this more
thoroughly. The author suggests that Arab women take pride in good health and would
not seek or believe in health care unless and otherwise indicated by illness. [106]. The
lack of folate consumption during the index pregnancy might relate back to this
element of considering a pregnancy as a sign of good health, thereby not seeking to
improve it for instance by consumption of folate. Secondly, it has been shown that
while a stable self-relevant disposition and self-esteem can be associated with health
promoting behaviors, stress and situationally evoked factors can be associated with a
practice of health impairing behaviors [107]. A history of RM is definitely a stressful
factor [108] which might reduce the changes of folate consumption. While the woman
might have been actively seeking to attain pregnancy, the stress of being pregnant
might constrain her health seeking behaviors unlike before, hence reducing the odds
that she consumes folate daily after conception.
Unfortunately, there seemed to be no effect of RM with future increase in physical
activity or reduction in sedentary behavior in the population. This seems to be in line
with physical activity in general among women in the UAE [109]. While appropriate
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lifestyle interventions can reduce the onset of adverse outcomes and improve health in
general, these did not seem to be occurring in the population. A simple explanation to
this is that intention does not always equate to behavior as theories such as the Theory
of Planned Behavior (TPB) suggest [110]. Although physical activity might have been
suggested by clinicians, it is unlikely to have made any effect if there was no onus of
control by the participants to change their other health related aspects such as physical
activity. As the diagram below suggests from the TPB, for a behavior to manifest itself
after intention (as the increased likelihood of planned pregnancy suggests), there must
be actual behavioral control.

Figure 6 : Theory of Planned Behavior as proposed by Icek Ajzen and illustrated by
Boissin et al. [111]
The lack of significance in physical activity or resting behaviors (sedentary behavior)
in the study is pertinent. In similar communities, women have associated physical
activity and lack of rest to the advent of miscarriages [104]. The need to prevent
physical activity and increase rest by women has been shown to be due to the
attribution of pregnancy as a vulnerable state [105]. Nevertheless, pregnant women,
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regardless of their history of loss, are encouraged to increase activity due to the benefits
that arise from it. These include reducing length of labor, delivery complications,
unnecessary weight gain, amongst others [106, 107].
For women to initiate better lifestyles such as increasing physical activity, folic acid
consumption throughout the conception and pregnancy periods, and other activities
which were not collected for this study, there must be several initiating factors as the
TPB suggests. While the past incidence of RM may initiate some belief in better
lifestyles in the future pregnancy, there needs to be more attributes that can convert
the intention to actual behavior. As there is no information via this study on what could
constitute the positive attitudes, subjective norms and behavioral controls for better
lifestyles in future pregnancies after RM, there is a need for further research on the
qualitative aspects of intention and behavior in the RM population.

4.2 RM Effec

n Pa ien

F ure Pregnancy Outcomes

With respect to outcomes in subsequent pregnancies, cesarean section, blood loss
during delivery and preterm birth were more likely to occur in women who have
suffered from RM regardless of the different definition classifications.
Jivraj et al. [112] conducted a cohort study of women (N=162) with a history of RM
in Sheffield (United Kingdom) from 01 January 1992 to 30 June 1998. Their study
explored the relationship between RM (defined as three or more consecutive losses)
and cesarean section, preterm delivery, and perinatal loss. This thesis also reported
similar independent associations between RM and cesarean section and preterm
delivery while using the updated 2018 ESHRE definition of RM.
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The effect of RM and cesarean section is highly controversial. While it can be related
back to cervical and placental competency, there is a subset of research that suggests
that the increase in cesarean section among patients with RM is due to a type of
caregiver bias [60]. It might be so that professionals choose to use the seemingly
simpler yet not safer mode of assisted delivery in high risk patients such as those with
RM [113].
Preterm delivery and pregnancy loss may share etiologic causes. It has been suggested
that both may be caused by genital infections which ascend through the vagina and
cervix [114]. Thereby, this leads to causing both spontaneous preterm labor and/or
preterm premature rupture of membranes. This same mechanism (infection) could also
be the reason for sporadic loss. Hence is it necessary to investigate women with the
susceptibility of genital infections or carriers of genital infections to be thoroughly
monitored for both miscarriage and preterm delivery once they conceive.
A novel and original finding in this thesis was the potential association between RM
and increased blood loss during delivery, however, the association became statistically
insignificant with the addition of cesarean section in the model. There are potentially
multiple explanations for this observation. Previous work has reported that placental
management is usually manual during cesarean section and that spontaneous expulsion
of the placenta is known to result in less blood loss as compared to manual removals
[115]. The increase in blood loss might also be related to placental insufficiency and
management, as well as trauma and uterine atony [116] which can occur as a result of
multiple miscarriages [117]. Cervical incompetence which might be another
confounding factor for RM and its association with cesarean section, preterm birth and
increased blood loss during delivery is also a classic reason for pregnancy loss [50]. It
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is also diagnosed after two consecutive losses further reiterating that two or more
consecutive losses were a good diagnostic definition for RM in this population.
Fortunately, in the case of cervical insufficiency which might be the primary cause of
RM [118], cervical cerclage can be performed to limit the occurrence of RM. Cervical
cerclage can also assist in reducing other future negative outcomes such as placental
abruption and preterm labor which was independently associated with a history of RM
(aOR: 2.52) in the population [119].
4.3 Chronology of RM and Its Effects
Relatively small differences were found between the chronology of the RM occurring
and its behaviors and outcomes effects during the index pregnancy. This seems to be
the consensus in most studies. Whether a woman has primary RM (losses with no
history of viable pregnancy), secondary RM (losses with viable pregnancies in
between them), the prognosis seems to be similar [68, 120]. However, some notable
differences can be seen.
Women with a history of primary RM were less likely to be consanguineous (aOR:
0.45) but more likely have an outcome of cesarean section (aOR: 2.28) compared to
women without primary RM. In previous studies exploring consanguinity and RM,
there seemed to be no differences between women with consanguineous marriages and
those without [121, 122]. However, a study from the Kingdom of Saudi Arabia which
investigates the relationship between consanguinity and RM found that women with
consanguineous marriages were more likely to have chromosomal abnormalities and
inherited thrombophilia. It was suggested that perhaps such an association had brought
about primary RM [79]. However, this does not seem to independently be shown when
comparing women with RM to those without and neither does it seem to correlate
when RM chronology was right before the index pregnancy (aOR: 1.21, 95% CI 0.61-
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2.41). More investigations are needed to understand chromosomal abnormalities in
women with RM throughout their reproductive career as in this synthesis a clear
association has not been found.
Furthermore, women with primary RM were more at risk of cesarean section in the
index pregnancy. There could be many explanations to this. With RM showing an
independent effect to cesarean section as an outcome, it is likely that women with
primary RM are more prone to cesarean sections from the beginning of their
reproductive career. It is known that women with previous cesarean section continue
to deliver via assisted deliveries throughout their future pregnancies [123]. It also
reiterates the previous discussion of caregiver bias when relating to cesarean section.
RM which occurs immediately before this index pregnancy had showed two
significant associations. Women with RM occurring before this index pregnancy were
more likely to have planned pregnancies and folate use before pregnancy than other
women with RM but not occurring immediately prior to the index pregnancy. This
seems to be a reoccurring theme for women with RM in general. It can be assumed
that the increased odds for women with RM before this index pregnancy could indicate
that the intention for women with recent RM to conceive and plan their pregnancy was
higher and hence adding healthy behaviors such as folate consumption before the index
pregnancy. However, further studies are needed to understand these nuances better.
4.4 Implications
4.4.1 Definition of RM for the UAE
B definition, a recurrent pregnanc loss is defined as the loss of more than one
pregnancy. The extent of this definition being extended to three or more or constricted
to two or more and why it is done is still unclear and based on different countries and
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different guidelines as mentioned in the introduction. To test these multiple definitions
and even the RM in the form of any losses (whether consecutive or not) was also
analyzed to understand their trajectories. Comparing prevalence estimates of RM
between studies can be challenging due to the use of different definitions (i.e. Two
versus three pregnancy losses as the cut-off for RM). Furthermore, whether a
consecutive or non-consecutive loss pertains to RM also differs between studies [124].
The denominator used to calculate loss also varies in many studies and includes
women at risk of RM having had two or more pregnancies, all women in their
reproductive years or women intending to conceive [34]. Accurate estimates of these
denominators are also difficult to obtain in many countries. In the neighboring regions,
both two consecutive losses [125] and three consecutive losses [121] have been used.
The only reports of RM in the UAE are those mentioned in fertility clinics. Even these
estimates, in some clinics in the UAE, are defined differently [126, 127].
The UAE is a rapidly developing high-income country with huge supply and demand
for maternal and child health [128]. In the emirate of Abu Dhabi, the total fertility rate
of citizens is 3.7 births per woman which is nearly double the total fertility rate in
developed countries in Asia, Europe, and North America [129]. It can be argued that
bearing in mind the fertility rate, three or more consecutive losses should be the rightful
definition for this population or pregnant women.
In addition, the prevalence estimates when using three or more consecutive losses as
the definition in the population (5.9%) was relatively closer to other estimates from
around the world (3- 5%) [130]. Comparatively, the study population had a higher rate
of 13.5% when using consecutive losses of two or more when looking at a population
of pregnant women. Thus, it might seem that two or more consecutive losses might
show a larger issue than should be. However, from a clinical point of view by leading
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organizations, it has been concluded by multiple international committees that defining
RM as two or more consecutive pregnancy losses will facilitate research, shared
decision-making, and enhance the psychological support available to couples [44].
Consequently, testing for antiphospholipid syndrome (APS), a treatable autoimmune
disorder and common cause of RM, can also be performed after two losses [43].
However, there must be some caution taken to the rates in the population of pregnant
women in this study. Most studies studying RM tend to recruit women with a history
of RM [55, 59, 71, 131]. In a similar study of women who were pregnant, the rate of
RM was 6.8% among a total cohort of 30,053 women with singleton pregnancies.
However, RM was defined having a history of three or more miscarriages [132]. This
is comparable to this population which had a rate of 5.9% for three or more consecutive
miscarriages. Nevertheless, the denominator of women at-risk as characteri ed in
this project s population, as women with a gravidity of three, was not clear in the study
by this study by Field et al. Another study, with a similar methodology as this thesis
addressing previous miscarriages, indicated that out of a total of 151,021 pregnancies,
700 of them occurred after two consecutive miscarriages. Again, a robust comparison
cannot be made between the two studies as the 151,021 included women of multiple
gravidities [57]. The Mutaba ah stud , in the future, would have 10,000 women and
baby pairs which would identify the population of RM in a methodical way. Other
studies using similar methodologies are required for appropriate comparison between
the Mutaba ah stud and its rates of RM. While two consecutive losses were used as
the main definition for RM in this study, it is still necessary for future research to
conduct some discriminatory analyses on which definition might be more appropriate
in flagging associations between RM and adverse outcomes.
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Nevertheless, rates of 5.9% for a history of three consecutive miscarriages and 13.5%
for a history of two or miscarriages amongst pregnant women are relatively high.
While it may not be conclusively said that it a cause for concern for the physicians and
healthcare professionals here, it is necessary for like-minded individuals to understand
the effects of RM better in the country. Moreover, in this population, women with a
history of RM, regardless of its definition, were at risk of future adverse outcomes
indicating the need for proper interventions for women who may suffer from RM. It
was shown that whether women had two or three consecutive losses, they seemed to
be more at risk of cesarean section, and preterm birth. They were also more inclined
to take folate before conceiving the index pregnancy, had planned pregnancies and
took no contraception preceding the index pregnancy. They were also more likely to
be employed, have more pregnancies and had previous infertility treatment. While the
exposure of three or more losses sometimes had a higher level of odds to the behaviors
and outcomes, both exposures still presented the risk of a history of RM to the
behaviors of the women during the index pregnancy and the outcomes they might face
if they had a future pregnancy. It is noteworthy to mention that some factors such as
age, ANC initiation and increased blood loss lost significance in the diagnostic
definition of three or more.
On the other hand, both the non-consecutive (and any type) definitions of RM were
not deemed suitable as they often did not show robust differences between the two
groups of women (RM versus no RM). Furthermore there is some evidence that shows
that whether the losses were consecutive or not does not impact the prognosis in RM
[133, 134]. Additionally literature has shown that, between the groups of all RM
couples, only a minority will go on to experience consecutive losses [46, 135]. There
was extensive work to see the effects of any loss (consecutive or not) on outcomes and
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behaviors. Some of the common significant outcomes, such as, cesarean section and
blood loss during delivery even lost significance when RM exposure was deemed as
any loss. It is however noteworthy to mention that when RM was defined as any loss
of two or more, it seemed to be an independent factor for lower odds of GDM (aOR:
0.63) and lower birth weight (aOR: 0.85). This is a rather peculiar association as a
history of RM has been shown to be associated with an increased risk of GDM [68].
Women with a history of RM have been shown to have small for gestational age
children when consuming medication such as aspirin to deal with their diagnosis [136].
In most literature, non-consecutive losses were not the indicative of poor prognosis in
the woman. This is because a live birth between losses seems to eradicate the negative
prognostic influence of pregnancy losses prior to birth [133].
Bearing these in mind and the fact that the subsequent behaviors and outcomes in
future pregnancies took a similar trajectory, whether it was following three or two
consecutive pregnancy losses or more, as shown above, it was a rigorously thought of
choice to use the ESHRE definition of RM as the standard for this study. This could
support that a history of two or more consecutive losses is an appropriate RM
definition for decision making, enhanced clinical support and for follow up. It is also
the notion of this thesis that over-investigation should be avoided, and greater
emphasis should be placed on treatment and care regardless of two or three consecutive
miscarriages. Hence, this thesis had conclusively used two or more consecutive losses
as the definition for RM for this population to study its chronology and effects. Women
are also often only provided investigations after three or more miscarriages as early
miscarriages are relatively common (RCOG). In note of this work however, it is
recommended that investigations on recurrent miscarriages occur once a woman has
experienced two miscarriages rather than after the third miscarriage [137].
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4.4.2 Early Pregnancy Loss Units
Most women who might miscarry in their early pregnancies are not given the care and
access to healthcare as might be necessary during such a difficult time, emotionally
and physically. In a busy place such as a tertiary hospital, women with early pregnancy
losses might often be treated crassly being given medication to miscarry completely at
home or sent to labor and delivery units to be monitored. The discussion on the setting
up of a model unit for early pregnancy assessment has been described elsewhere [138].
There also seem to be such units around the country in Dubai and Abu Dhabi.
The relatively high rate of RM in this population of pregnant women necessitates an
imperative need for the major hospitals in the city of Al Ain to set up early pregnancy
assessment units. These centers would allow for quick turnaround time for
obstetricians to test viability of pregnancies. It would also highlight women with risks
of adverse outcomes such as ectopic pregnancies, GDM and hypertension or other
issues such as pain, bleeding or excessive symptoms. Women with recurrent losses can
be followed up closely with increased number of visits. Furthermore, if they go on to
unfortunately lose their pregnancy, they would be followed up quicker and efficiently.
4.5 Methodological Considerations
This dissertation described recurrent miscarriage in the pregnant Emirati population in
Al Ain city, UAE. This is the first study, based on current knowledge, with such
extensive work done on RM in the country. Furthermore, it is essentially the first work
to establish a prevalence of RM to dedicate clinical support for these patients. Multiple
outcomes as well as behaviors were analyzed to investigate their association with RM.
The relatively large sample size and detailed dataset permitted robust analyses of less
common but important outcomes such as preterm and very preterm birth. However,
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all epidemiological studies have strengths and challenges depending on the design and
methodology of the study. This section will discuss the strength and limitations of this
study.
4.5.1 Study Design
Observational cohort studies are one of the most powerful design in epidemiological
research as they provide a robust basis of evidence in many areas of research. A cohort
is defined as a population or group of individuals who are followed over time. Usually
this population share common characteristics. Cohort studies present numerous
advantages and caveats. In mother and child health research, these studies are able to
capture dynamic exposures and their outcomes over a period of time. As well as being
appropriate to investigate exposures such as recurrent miscarriage, they allow to
explore the transition, patterns and changes in exposure over time. A robust and
longitudinal design also allow for flexibility in terms of exposure and outcome
ascertainment.
Cohort studies are, however, disadvantageous in other ways. Attrition rates are
prevalent due to follow up and retaining individuals in multiple populations are hard.
They are also labor intensive and costly.
4.5.2 Internal and External Validity
The internal validity of a study is characterized by whether the inferences in the study
are robust while external validit is categori ed b whether a stud s results can be
extrapolated to populations larger than that studied [139]. In this section, factors that
allowed for the validity of the thesis will be discussed.
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4.5.2.1 Selection Bias
Selection bias is a systematic error which occurs as a result of the procedures used to
select subjects for the study and the factors that influence participation. The definition
used is that the association between exposures and outcomes among those selected
for analysis differs from the association among those eligible [140]. Generally,
selection bias is a problem if the representativeness of the participants is not true to the
population included in the study. Those who participate and do not participate might
have different associations between exposures and outcomes. Selection bias manifests
in multiple ways such as the loss to follow up, healthy-worker bias and nonresponse
bias.
In this current study, selection bias was well managed. Refusal rates were relatively
low compared to other maternal and child cohorts at 12.5% [72, 84]. In order to
minimize selection bias, a representative sample of the population was recruited by
using the main public and private hospitals as recruitment sites with multiple recruiters
at each location staggered throughout clinic hours. The Emirati population has full
health insurance coverage providing them with the same level of health care at any
health facility. As such, there is no difference in healthcare access between pregnant
women attending these three hospitals and those who use other institutions. Therefore,
a representative sample of the Emirati population in Al Ain can be recruited from these
three hospitals. Furthermore, recruitment is done via consecutive sampling. Every
single woman who might appear to meet the inclusion criteria is approached. Hence,
self-selection bias, which occurs when participants who are health conscious or more
worried about their health and agree to participate, is reduced.
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4.5.2.2 Information Bias
Information bias, otherwise known as misclassification, is another type of systematic
error resulting from erroneous collection of information, originating from the approach
that is utilized to obtain study measurements such as that of questionnaires and medical
records such as that of this study [141]. The error in providing information about
exposure or outcome can result in the subject being misclassified into the wrong
category. A common type of information bias is that of recall. It is noted that there is
a specific type of recall bias which occurs specifically in mothers named maternal
recall bias. Mothers of healthy or normal babies tend to not have comparable stimuli
to remember issues regarding their pregnancy or birth as compared to mothers of
children with issues or health ailments.
In this study, all questions were framed with exact timings to achieve appropriate
recall. For example, to ensure that contraceptive use was based on the index pregnancy,
the question on contraception was framed to ask the participant to recall her use in the
last year.
To further reduce misclassification, all the data used to categorize women into RM or
non-RM groups were from a more robust data source

medical records. As medical

records were the basis of this analysis, it is assumed that the pregnancies, their dating,
and outcomes were accurate. Hospitals tend to collect information on loss via delivery
records and hospital admissions; hence this reduces the need for mothers to recall their
previous losses. However, electronic medical records also face erroneous and missing
data which can in return affect the inferences of research. The misclassification of
miscarriages in past pregnancies can underestimate or enlarge the rate of RM in the
population. To circumvent this, multiple variables measuring similar observations
were collected from the medical records. For the ascertainment of the status of RM in

87
this population, information was collected about each of the participant s previous
pregnancies as well as a snapshot of the outcomes of all her pregnancies, whether they
resulted in a live birth or miscarriage. In this way, data regarding miscarriages can be
confirmed via multiple medical record variables. All other variables that can be
checked via this way were also inspected to ensure enhanced data quality.
Medically advised abortions can also be a form of misclassification bias.
Unfortunately, whether a previous miscarriage was medically advised was not
established well in the medical records collected. While it was attested if the
miscarriages had a dilation and curettage (D&C), it could not be specifically attributed
to whether it was medically advised. Although, it would have been interesting to
understand the differentiation between spontaneous and medically managed
miscarriages, both are inherently miscarriages and can be classified as such.
Nevertheless, in the future, the use of physician and nurse notes can illuminate such
differences in miscarriage treatment and interventions.
4.5.2.3 Confounding
Any epidemiological study can face the issue of confounding. Confounding is a
distortion in the estimated measure of association when the primary exposure of
interest is mixed up with some other factor that is associated with the outcome [142].
Confounding was dealt with via a few ways in this study. Firstly, the study size is
sufficiently large such that all potential confounding variables which are known or
unknown will be distributed by chance across the groups. Furthermore, all regression
models were adjusted for commonly interfering factors such as age, parity and so on.
It is, however, noteworthy that some level of residual confounding might remain in the
study.
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4.5.2.4 Random Error
The above types of errors were systematic. The error that remains once those have
been dealt with is the random error. Random error is essentially the variability that is
observed that cannot be easily explained or is due to chance. In this study, random
error can account for having a history of RM due to unknown factors or not collected
factors in the study. To circumvent this issue, the Mutaba ah stud has envisioned to
recruit 10,000 women. This is sufficiently large sample size to increase precision. One
of the strengths of this study as well is that the sample size was adequately powered.
The overall sample size to calculate exposure to RM was 1700 whilst in this study,
there were 1737 women with a gravidity of two or more to pursue this. This study is
also the largest RM study in the region.
Furthermore, the use of p-values and confidence intervals for a broad range of possible
parameters that could have been caused or impacted by RM can reduce the impact of
random error. Using the 95% confidence interval with an alpha of 0.05 will ensure that
the frequency with which the interval will contain the true parameter of odds will be
at least 95%.
4.6 Future Directions
One of the significant reflections of this study was that to conduct idyllic
epidemiological research, with both medical records and surveys from participants,
there must be synergy between these two tools. Both medical records and surveys seek
to understand the participant and obtain health related information. For this synergy to
happen seamlessly, these tools need to complement each other. Medical record
collection and collation must have research as a secondary objective. Data that is
complete, accurate and structured in medical records will be beneficial for researchers
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intending to better understand population health and provide better clinical decision
support. Conversations need to consistently happen between researchers and
healthcare professionals such that the different tools supplement each other.
Furthermore, in hospitals and other medical institutions, improving how data is
collected and stored is not only useful for research. It will assist in optimal and accurate
care provision due to quality data. This is especially important for a population like
that of women with a history of RM. The RM population can be studied and followed
up in an appropriate manner if the different data sources which provide the required
data used to study them complement each other.
There are also many other ways for the RM literature to flourish and provide essential
information for appropriate intervention and care to these women. Some of these
methods will be discussed below.
4.6.1 Prospective Cohort Studies
Prospective studies will be warranted to investigate the incidence rates and risk factors
for RM in the UAE and the region. These studies will provide more understanding of
the epidemiology of RM and quantify the immediate physical and emotional
consequences. For a study to systematically recruit women who might likely lose their
pregnancy, the recruitment must start way before conception so that careful and
uniform monitoring could identify losses at the earliest gestations. Like other
successful studies around the world which have studied miscarriages and other
pregnancy losses, women who intend to get pregnant should be followed up once this
intention is noted. As such, conception times, early scans and any losses, if it
unfortunately occurs, can all be systematically collated by the participant or their
visited facilities.
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An example of such a data collection is described by Wildenschild et al. [143], that
studied Danish female residents, 18 40 years old at study enrolment, in a relationship
with a male partner, attempting to conceive and not receiving fertility treatment. Out
of all potential participants, only women who were pregnant at least once before and
ending up pregnant again were recruited. Women completed questionnaires and their
medical data was extracted from patient registries and birth registries. This type of
follow ups and study designs allow for a clean sample of women who might go on to
have miscarriages.
The Mutaba ah stud will go on to follow up this population until their offspring turn
16. This opens many doors for future reassessment of the effects of RM on the
population. The rigorous use of medical record extractions that can indicate if the
woman goes on to have future pregnancies and if they end up in losses will be
collected. This will essentially create a generous databank for like-minded individuals
to study the effect of RM on many more outcomes in the mother and even the child.
Furthermore, RM literature which heavily focuses on future pregnancy outcome can
be further supplemented b the Mutaba ah stud s longitudinal nature.
4.6.2 Qualitative Studies
Women with a history of RM must not feel that their outcome is an invisible one as is
conveniently often mentioned. RM holds as much trauma and poor outcomes as other
more studied exposures. There has been some interest into this with a study from the
UAE understanding the perceptions of RM on the psychological aspects of women
[76]. Although this thesis demonstrated the effects of history of RM on future
pregnancies, the nuances of pregnancy planning, intentions during and before the
pregnancy and feelings after a birth after RM cannot be captured by such a quantitative
study design.
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A qualitative study will therefore be the optimal design to investigate this and allow
the understanding of why women were not accepting better behaviors despite the
history of RM. Such studies were not done anywhere in the world before. If the reasons
for non-consumption of folic acid during pregnancy, physical activity, and increased
sedentary behavior can be easily tracked, interventions for better lifestyle behaviors
can be proposed. It is not appropriate to assume that women are in general goaloriented and will not act better during their pregnancies. Only a true account of women
with histories of RM and what hinders them from better behaviors will enlighten the
scientific community better.
Some queries in this qualitative field might include, what have been the thoughts of
women with histories if RM in their reproductive career, what are the discussions they
have with their community and spouse, what changes have occurred from the time of
RM till the present, what different decisions are made by the women and their spouse
and what they believe could have been the reason for RM. Furthermore, healthcare
professionals, cultural and religious experts should also weigh in on understanding the
effects of a history of RM on future behaviors of women in the country.
4.6.3 The Power of Artificial Intelligence
AI has gained significant attention in recent years because of its successful application
in robotics, Natural language processing, voice and image recognition and other
solutions. In medicine and healthcare, AI involvement probably began with the clinical
decision support systems that saw much success in healthcare. The rapidly increasing
advancement in computing power and capability are used to handle and utilize the
huge loads of health data generated by various health service facilities and governing
entities. AI has provided advances in predictive models and makes real time inferences
on alerting the patient and the physician, stratifying risks of the patients and predicts
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the use of healthcare facilities. There is a growing scientific interest to develop and
provide more comprehensive AI-based solutions to healthcare services. Such solutions
can cover three broad areas, namely, 1) data collection and storage, 2) data quality
enhancement and 3) building of clinical decision support systems.
One of the biggest challenges of this dissertation as well as the overall project was the
linkage between epidemiological data collected from the respondents and the medical
record data collected from the hospitals. Hospitals collect extremely diverse, varied
and robust data. The use of AI in longitudinal studies are relatively novel and might
reduce the need for multi-center monitoring and verification. Furthermore, a
homogenous database can be created where data in different forms (i.e. image, text,
structured) are collated in a single system, it would create immense reduction in
workload and mone . The Mutaba ah stud ma mimic a real clinical setting where
data is heterogeneous and large in quantity and the use of intelligent systems like
central statistical monitoring, deep learning networks and more would reap maximum
benefits in healthcare. Although AI has shown much success in narrow domains, the
challenge now is to apply into a wider-purpose, multimodality data system such as that
of Mutaba ah or similar cohort studies.
Furthermore, AI application can be developed to target better prediction of future risks
and consequences in women with history of RM. Such predictions can be personalized
to each patient depending on specific characteristics and number, consecutiveness and
chronology of RM.
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Chapter 5: Conclusion

In conclusion to this dissertation, the prevalence of RM is high with about 13.5% of
women having had a history of RM prior to the index pregnancy. In terms of behaviors
in their index pregnancy, women with a history of RM were more likely to have
planned pregnancies, not use contraception, consume folic acid prior to the index
pregnancy and initiate antenatal care on time. Women with a history of RM were more
likely to have cesarean section deliveries, preterm and very preterm births and have
more loss of blood during delivery of the index pregnancy. Women with a history of
RM occurring immediately before the index pregnancy were more likely to have
planned pregnancies and increased consumption of folate before the pregnancy while
women with a history of primary RM were less likely to have consanguineous
marriages and have an independent association to undergoing cesarean section. The
dissertation also discussed what the best definition for the UAE was. RM could be best
defined as two or more consecutive losses in the population.
RM in its entirety is a clinical conundrum. While its diagnosis is difficult for the
sufferer, its prognosis also requires attention. While all the women in this population
with a history of live births went on to have majority live births, the adverse outcomes
such as cesarean section, preterm births and increased blood loss during delivery are
important events that should be reduced. Early pregnancy monitoring units enhanced
clinical data which will in turn lead to better clinical decision making and good follow
ups will ensure the best health for women and their children in the UAE.
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